The mitochondrion is the most important organelle in determining continued cell survival and cell death. Mitochondrial dysfunction leads to many human maladies, including cardiovascular diseases, neurodegenerative disease, and cancer. These mitochondria-related pathologies range from early infancy to senescence. The central premise of this review is that if mitochondrial abnormalities contribute to the pathological state, alleviating the mitochondrial dysfunction would contribute to attenuating the severity or progression of the disease. Therefore, this review will examine the role of mitochondria in the etiology and progression of several diseases and explore potential therapeutic benefits of targeting mitochondria in mitigating the disease processes. Indeed, recent advances in mitochondrial biology have led to selective targeting of drugs designed to modulate and manipulate mitochondrial function and genomics for therapeutic benefit. These approaches to treat mitochondrial dysfunction rationally could lead to selective protection of cells in different tissues and various disease states. However, most of these approaches are in their infancy. Antioxid. Redox Signal. 13, 279–347.
AbeteP, TestaG, FerraraN, De SantisD, CapaccioP, ViatiL, CalabreseC, CacciatoreF, LongobardiG, CondorelliM, NapoliC, RengoF. Cardioprotective effect of ischemic preconditioning is preserved in food-restricted senescent rats. Am J Physiol Heart Circ Physiol, 282:H1978–H1987. 2002.
2.
Abu–HamadS, ZaidH, IsraelsonA, NahonE, Shoshan–BarmatzV. Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: Mapping the site of binding. J Biol Chem, 283:13482–13490. 2008.
3.
AdamsJM, CoryS. The Bcl-2 protein family: Arbiters of cell survival. Science, 281:1322–1326. 1998.
AdrainC, CreaghEM, MartinSJ. Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. EMBO J, 20:6627–6636. 2001.
6.
AhtoniemiT, JaronenM, Keksa–GoldsteineV, GoldsteinsG, KoistinahoJ. Mutant SOD1 from spinal cord of G93A rats is destabilized and binds to inner mitochondrial membrane. Neurobiol Dis, 32:479–485. 2008.
7.
AldakkakM, CamaraAKS, PatelR, HaumannJ, RhodesSS, StoweDF. Inactivation of cardiac mitochondrial K/H exchange by quinine exposes matrix acidification and K+ influx by putative Ca2+dependent K+ channels [abstract]J Biophysics, 436-pos. 2008.
8.
AldakkakM, HeisnerJS, CamaraAKS, HaumannJ, StoweDF. Ranolazine, a late sodium current inhibitor, reduces ischemia-induced superoxide emission and improves functional recovery in guinea pig hearts. FASEB J, 793:17pos. 2009.
9.
AldakkakM, StoweDF, ChenQ, LesnefskyEJ, CamaraAK. Inhibited mitochondrial respiration by amobarbital during cardiac ischaemia improves redox state and reduces matrix Ca2+ overload and ROS release. Cardiovasc Res, 77:406–415. 2008.
10.
AldakkakM, StoweDF, HeisnerJS, SpenceM, CamaraAK. Enhanced Na+/H+ exchange during ischemia and reperfusion impairs mitochondrial bioenergetics and myocardial function. J Cardiovasc Pharmacol, 52:236–244. 2008.
11.
AldakkakM, StoweDF, HeisnerJS, HaumannJ, CamaraAKS. Blocking mitochondrial Ca2+ uniporter activity during activated Na+/H+ exchange reduces Ca2+ loading but does little to better protect function on reperfusion. FASEB J, 730:24pos. 2008.
12.
AldakkakMH, StoweDF, ChenQ, LesnefskyEJ, HeinenA, RhodesSS, CamaraAKS. Amobarbital, high K+ and lidocaine protect heart against ischemia reperfusion injury by differential changes in mitochondrial bioenergetics. FASEB J, 20:A384. 2006.
13.
AlexanderGC, SehgalNL, MoloneyRM, StaffordRS. National trends in treatment of type 2 diabetes mellitus, 1994–2007. Arch Intern Med, 168:2088–2-94. 2008.
14.
AmbrosioG, ZweierJL, DuilioC, KuppusamyP, SantoroG, EliaPP, TrittoI, CirilloP, CondorelliM, ChiarielloMet al.Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J Biol Chem, 268:18532–18541. 1993.
15.
AndersonEJ, LustigME, BoyleKE, WoodliefTL, KaneDA, LinCT, PriceJW3rd, KangL, RabinovitchPS, SzetoHH, HoumardJA, CortrightRN, WassermanDH, NeuferPD. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest, 119:573–581. 2009.
16.
AndersonPR, KirbyK, HillikerAJ, PhillipsJP. RNAi-mediated suppression of the mitochondrial iron chaperone, frataxin, in Drosophila. Hum Mol Genet, 14:3397–3405. 2005.
17.
AndersonPR, KirbyK, OrrWC, HillikerAJ, PhillipsJP. Hydrogen peroxide scavenging rescues frataxin deficiency in a Drosophila model of Friedreich's ataxia. Proc Natl Acad Sci USA, 105:611–616. 2008.
18.
AndersonTC, LiCQ, ShaoZH, HoangT, ChanKC, HamannKJ, BeckerLB, Vanden, HoekTL. Transient and partial mitochondrial inhibition for the treatment of postresuscitation injury: getting it just right. Crit Care Med, 34:S474–S482. 2006.
19.
AndohT, ChockPB, MurphyDL, ChiuehCC. Role of the redox protein thioredoxin in cytoprotective mechanism evoked by (-)-deprenyl. Mol Pharmacol, 68:1408–1414. 2005.
AndrienkoT, KuznetsovAV, KaambreT, UssoNY, OroscoA, AppaixF, TiivelT, SikkP, VendelinM, MargreiterR, SaksVA. Metabolic consequences of functional complexes of mitochondria, myofibrils and sarcoplasmic reticulum in muscle cells. J Exp Biol, 206:2059–2072. 2003.
22.
AnetorJI, AsiriboOA, AdedapoKS, AkingbolaTS, OlorunnisolaOS, AdeniyiFA. Increased plasma manganese, partially reduced ascorbate, 1 and absence of mitochondrial oxidative stress in type 2 diabetes mellitus: Implications for the superoxide uncoupling protein 2 (UCP-2) pathway. Biol Trace Elem Res, 120:19–27. 2007.
23.
AntunesF, HanD, CadenasE. Relative contributions of heart mitochondria glutathione peroxidase and catalase to H(2)O(2) detoxification in in vivo conditions. Free Radic Biol Med, 33:1260–1267. 2002.
24.
AonMA, CortassaS, AkarFG, O'RourkeB. Mitochondrial criticality: A new concept at the turning point of life or death. Biochim Biophys Acta, 1762:232–240. 2006.
25.
AonMA, CortassaS, MaackC, O'RourkeB. Sequential opening of mitochondrial ion channels as a function of glutathione redox thiol status. J Biol Chem, 282:21889–21900. 2007.
26.
AppaixF, KuznetsovAV, UssoNY, KayL, AndrienkoT, OlivaresJ, KaambreT, SikkP, MargreiterR, SaksV. Possible role of cytoskeleton in intracellular arrangement and regulation of mitochondria. Exp Physiol, 88:175–190. 2003.
27.
ArakiE, MiyazakiJ. Metabolic disorders in diabetes mellitus: Impact of mitochondrial function and oxidative stress on diabetes and its complications. Antioxid Redox Signal, 9:289–291. 2007.
28.
ArmstrongJS. Mitochondrial medicine: Pharmacological targeting of mitochondria in disease. Br J Pharmacol, 151:1154–1165. 2007.
AzzuV, ParkerN, BrandMD. High membrane potential promotes alkenal-induced mitochondrial uncoupling and influences adenine nucleotide translocase conformation. Biochem J, 413:323–332. 2008.
33.
BaY, ZhangY, ZhangCY. [Peroxisome proliferator activated receptor gamma coactivator-1 induces apoptosis in human epithelial ovarian cancer cells]Zhonghua Yi Xue Za Zhi, 87:1430–1433. 2007.
BagchiD, BagchiM, HassounEA, KellyJ, StohsSJ. Adriamycin-induced hepatic and myocardial lipid peroxidation and DNA damage, and enhanced excretion of urinary lipid metabolites in rats. Toxicology, 95:1–9. 1995.
36.
BainesCP, KaiserRA, PurcellNH, BlairNS, OsinskaH, HambletonMA, BrunskillEW, SayenMR, GottliebRA, DornGW, RobbinsJ, MolkentinJD. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature, 434:658–662. 2005.
37.
BainesCP, KaiserRA, SheikoT, CraigenWJ, MolkentinJD. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol, 9:550–555. 2007.
38.
BainesCP, SongCX, ZhengYT, WangGW, ZhangJ, WangOL, GuoY, BolliR, CardwellEM, PingP. Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res, 92:873–880. 2003.
39.
BanciL, BertiniI, BocaM, GirottoS, MartinelliM, ValentineJS, VieruM. SOD1 and amyotrophic lateral sclerosis: Mutations and oligomerization. PLoS ONE, 3:e1677. 2008.
40.
BanerjeeR, StarkovAA, BealMF, ThomasB. Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis. Biochim Biophys Acta, 1792:651–663. 2009.
BarreiroE, Garcia–MartinezC, MasS, AmetllerE, GeaJ, ArgilesJM, BusquetsS, Lopez–SorianoFJ. UCP3 overexpression neutralizes oxidative stress rather than nitrosative stress in mouse myotubes. FEBS Lett, 583:350–356. 2009.
43.
BassoE, FanteL, FowlkesJ, PetronilliV, ForteMA, BernardiP. Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J Biol Chem, 280:18558–18561. 2005.
44.
BatesTE, LoeschA, BurnstockG, ClarkJB. Mitochondrial nitric oxide synthase: A ubiquitous regulator of oxidative phosphorylation?Biochem Biophys Res Commun, 218:40–44. 1996.
45.
BaudryM, EtienneS, BruceA, PaluckiM, JacobsenE, MalfroyB. Salen-manganese complexes are superoxide dismutase-mimics. Biochem Biophys Res Commun, 192:964–968. 1993.
46.
BaudryN, LaemmelE, VicautE. In vivo reactive oxygen species production induced by ischemia in muscle arterioles of mice: Involvement of xanthine oxidase and mitochondria. Am J Physiol Heart Circ Physiol, 294:H821–H828. 2008.
47.
BeardDA. A biophysical model of the mitochondrial respiratory system and oxidative phosphorylation. PLoS Comput Biol, 1:e36. 2005.
48.
BellEL, KlimovaT, ChandelNS. Targeting the mitochondria for cancer therapy: Regulation of hypoxia-inducible factor by mitochondria. Antioxid Redox Signal, 10:635–640. 2008.
49.
BenovL, SztejnbergL, FridovichI. Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radic Biol Med, 25:826–831. 1998.
50.
BenschKG, DegraafW, HansenPA, ZassenhausHP, CorbettJA. A transgenic model to study the pathogenesis of somatic mtDNA mutation accumulation in beta-cells. Diabetes Obes Metab, 9:74–80. 2007.
51.
BenschKG, MottJL, ChangSW, HansenPA, MoxleyMA, ChambersKT, de GraafW, ZassenhausHP, CorbettJA. Selective mtDNA mutation accumulation results in {beta}-cell apoptosis and diabetes development. Am J Physiol Endocrinol Metab, 296:E672–E680. 2009.
52.
BentonCR, NickersonJG, LallyJ, HanXX, HollowayGP, GlatzJF, LuikenJJ, GrahamTE, HeikkilaJJ, BonenA. Modest PGC-1α overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria. J Biol Chem, 283:4228–4240. 2008.
53.
BernardiP. Mitochondrial transport of cations: Channels, exchangers, and permeability transition. Physiol Rev, 79:1127–1155. 1999.
54.
BersinRM, StacpoolePW. Dichloroacetate as metabolic therapy for myocardial ischemia and failure. Am Heart J, 134:841–855. 1997.
Birch–MachinMA. The role of mitochondria in ageing and carcinogenesis. Clin Exp Dermatol, 31:548–552. 2006.
57.
BladeJ, RosinolL. Advances in therapy of multiple myeloma. Curr Opin Oncol, 20:697–704. 2008.
58.
BlaikieFH, BrownSE, SamuelssonLM, BrandMD, SmithRA, MurphyMP. Targeting dinitrophenol to mitochondria: Limitations to the development of a self-limiting mitochondrial protonophore. Biosci Rep, 26:231–243. 2006.
59.
BorutaiteV, BrownGC. S-nitrosothiol inhibition of mitochondrial complex I causes a reversible increase in mitochondrial hydrogen peroxide production. Biochim Biophys Acta, 1757:562–566. 2006.
60.
BossO, SamecS, Paoloni–GiacobinoA, RossierC, DullooA, SeydouxJ, MuzzinP, GiacobinoJP. Uncoupling protein-3: A new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett, 408:39–42. 1997.
61.
BottoN, BertiS, ManfrediS, Al–JabriA, FedericiC, ClericoA, CiofiniE, BiaginiA, AndreassiMG. Detection of mtDNA with 4977 bp deletion in blood cells and atherosclerotic lesions of patients with coronary artery disease. Mutation Research, 570:81–88. 2005.
62.
BoudinaS, SenaS, TheobaldH, ShengX, WrightJJ, HuXX, AzizS, JohnsonJI, BuggerH, ZahaVG, AbelED. Mitochondrial energetics in the heart in obesity-related diabetes: Direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes, 56:2457–2466. 2007.
63.
BoverisA, ChanceB. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J, 134:707–716. 1973.
64.
BoverisA, CostaLE, PoderosoJJ, CarrerasMC, CadenasE. Regulation of mitochondrial respiration by oxygen and nitric oxide. Ann NY Acad Sci, 899:121–135. 2000.
65.
BradyNR, Hamacher–BradyA, GottliebRA. Proapoptotic BCL-2 family members and mitochondrial dysfunction during ischemia/reperfusion injury, a study employing cardiac HL-1 cells and GFP biosensors. Biochim Biophys Acta, 1757:667–678. 2006.
66.
BradyNR, Hamacher–BradyA, WesterhoffHV, GottliebRA. A wave of reactive oxygen species (ROS)-induced ROS release in a sea of excitable mitochondria. Antioxid Redox Signal, 8:1651–1665. 2006.
67.
BrennerC, GrimmS. The permeability transition pore complex in cancer cell death. Oncogene, 25:4744–4756. 2006.
68.
BristowM. Etomoxir: A new approach to treatment of chronic heart failure. Lancet, 356:1621–1622. 2000.
69.
BrookesPS. Mitochondrial proton leak and superoxide generation: An hypothesis. Biochem Soc Trans, 26:S331. 1998.
70.
BrookesPS. Mitochondrial H+ leak and ROS generation: An odd couple. Free Radic Biol Med, 38:12–23. 2005.
71.
BrookesPS, YooNY, RobothamJL, AndersMW, SheuSS. Calcium, ATP, and ROS: A mitochondrial love–hate triangle. Am J Physiol Cell Physiol, 287:C817–C833. 2004.
72.
BrooksC, DongZ. Regulation of mitochondrial morphological dynamics during apoptosis by Bcl-2 family proteins: A key in Bak?Cell Cycle, 6:3043–3047. 2007.
73.
BrooksC, WeiQ, FengL, DongG, TaoY, MeiL, XieZJ, DongZ. Bak regulates mitochondrial morphology and pathology during apoptosis by interacting with mitofusins. Proc Natl Acad Sci USA, 104:11649–11654. 2007.
74.
BrownDA, AonMA, AkarFG, LiuT, SorarrainN, O'RourkeB. Effects of 4'-chlorodiazepam on cellular excitation-contraction coupling and ischaemia-reperfusion injury in rabbit heart. Cardiovasc Res, 79:141–149. 2008.
75.
BrownWM, GeorgeMJr., WilsonAC. Rapid evolution of animal mitochondrial DNA. Proc Natl Acad Sci USA, 76:1967–1971. 1979.
76.
BruceAJ, MalfroyB, BaudryM. beta-Amyloid toxicity in organotypic hippocampal cultures: Protection by EUK-8, a synthetic catalytic free radical scavenger. Proc Natl Acad Sci USA, 93:2312–2316. 1996.
77.
BrunmairB, StaniekK, GrasF, ScharfN, AlthaymA, ClaraR, RodenM, GnaigerE, NohlH, WaldhauslW, FurnsinnC. Thiazolidinediones, like metformin, inhibit respiratory complex I: A common mechanism contributing to their antidiabetic actions?Diabetes, 53:1052–1059. 2004.
78.
BrysonJM, CoyPE, GottlobK, HayN, RobeyRB. Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death. J Biol Chem, 277:11392–11400. 2002.
79.
BubberP, HaroutunianV, FischG, BlassJP, GibsonGE. Mitochondrial abnormalities in Alzheimer brain: mMechanistic implications. Ann Neurol, 57:695–703. 2005.
80.
BulteauAL, LundbergKC, Ikeda–SaitoM, IsayaG, SzwedaLI. Reversible redox-dependent modulation of mitochondrial aconitase and proteolytic activity during in vivo cardiac ischemia/reperfusion. Proc Natl Acad Sci USA, 102:5987–5991. 2005.
81.
BurwellLS, BrookesPS. Mitochondria as a target for the cardioprotective effects of nitric oxide in ischemia-reperfusion injury. Antioxid Redox Signal, 10:579–599. 2008.
82.
BurwellLS, NadtochiySM, BrookesPS. Cardioprotection by metabolic shut-down and gradual wake-up. J Mol Cell Cardiol, 46:804–810. 2009.
83.
CadenasE, BoverisA. Enhancement of hydrogen peroxide formation by protophores and ionophores in antimycin-supplemented mitochondria. Biochem J, 188:31–37. 1980.
84.
CadenasE, BoverisA, RaganCI, StoppaniAO. Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria. Arch Biochem Biophys, 180:248–257. 1977.
CalabreseV, RavagnaA, ColombritaC, ScapagniniG, GuaglianoE, CalvaniM, ButterfieldDA, Giuffrida StellaAM. Acetylcarnitine induces heme oxygenase in rat astrocytes and protects against oxidative stress: Involvement of the transcription factor Nrf2. J Neurosci Res, 79:509–521. 2005.
88.
Caldeira da SilvaCC, CerqueiraFM, BarbosaLF, MedeirosMH, KowaltowskiAJ. Mild mitochondrial uncoupling in mice affects energy metabolism, redox balance and longevity. Aging Cell, 7:552–560. 2008.
89.
Calderon–CortesE, Cortes–RojoC, Clemente–GuerreroM, Manzo–AvalosS, Villalobos–MolinaR, BoldoghI, Saavedra–MolinaA. Changes in mitochondrial functionality and calcium uptake in hypertensive rats as a function of age. Mitochondrion, 8:262–272. 2008.
90.
CamaraA, AldakkakM, HeisnerJS, RhodesSS, RiessML, AnJ, HeinenA, StoweDF. ROS scavenging before 27°C ischemia protects hearts and reduces mitochondrial ROS, Ca2+ overload, and changes in redox state. Am J Physiol Cell Physiol, 292:C2021–C2031. 2007.
91.
CamaraAK, RiessML, KevinLG, NovalijaE, StoweDF. Hypothermia augments reactive oxygen species detected in the guinea pig isolated perfused heart. Am J Physiol Heart Circ Physiol, 286:H1289–H1299. 2004.
92.
CamiciGG, CosentinoF, TannerFC, LuscherTF. The role of p66Shc deletion in age-associated arterial dysfunction and disease states. J Appl Physiol, 105:1628–1631. 2008.
93.
CandeC, CecconiF, DessenP, KroemerG. Apoptosis-inducing factor (AIF): Key to the conserved caspase-independent pathways of cell death?J Cell Sci, 115:4727–4734. 2002.
94.
CanninoG, Di LiegroCM, RinaldiAM. Nuclear–mitochondrial interaction. Mitochondrion, 7:359–366. 2007.
CarlssonLM, JonssonJ, EdlundT, MarklundSL. Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia. Proc Natl Acad Sci USA, 92:6264–6268. 1995.
99.
CassinaP, CassinaA, PeharM, CastellanosR, GandelmanM, de LeonA, RobinsonKM, MasonRP, BeckmanJS, BarbeitoL, RadiR. Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: Prevention by mitochondrial-targeted antioxidants. J Neurosci, 28:4115–4122. 2008.
100.
CavalliLR, Varella–GarciaM, LiangBC. Diminished tumorigenic phenotype after depletion of mitochondrial DNA. Cell Growth Differ, 8:1189–1198. 1997.
101.
CertoM, Del Gaizo MooreV, NishinoM, WeiG, KorsmeyerS, ArmstrongSA, LetaiA. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell, 9:351–365. 2006.
102.
ChaeHZ, KangSW, RheeSG. Isoforms of mammalian peroxiredoxin that reduce peroxides in presence of thioredoxin. Methods Enzymol, 300:219–226. 1999.
103.
ChaeHZ, KimHJ, KangSW, RheeSG. Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res Clin Pract, 45:101–112. 1999.
104.
ChampagneE, MartinezLO, ColletX, BarbarasR. Ecto-F1Fo ATP synthase/F1 ATPase: Metabolic and immunological functions. Curr Opin Lipidol, 17:279–284. 2006.
105.
ChanDC. Mitochondria: Dynamic organelles in disease, aging, and development. Cell, 125:1241–1252. 2006.
106.
ChanPH. Reactive oxygen radicals in signaling and damage in the ischemic brain. [Review]J Cerebral Blood Flow Metab, 21:2–14. 2001.
107.
ChanSH, WuKL, ChangAY, TaiMH, ChanJY. Oxidative impairment of mitochondrial electron transport chain complexes in rostral ventrolateral medulla contributes to neurogenic hypertension. Hypertension, 53:217–227. 2009.
108.
ChandelNS, McClintockDS, FelicianoCE, WoodTM, MelendezJA, RodriguezAM, SchumackerPT. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: A mechanism of O2 sensing. J Biol Chem, 275:25130–25138. 2000.
109.
ChaudhryP, AsselinE. Resistance to chemotherapy and hormone therapy in endometrial cancer. Endocr Relat Cancer, 16:363–380. 2009.
ChazotteB, VanderkooiG. Multiple sites of inhibition of mitochondrial electron transport by local anesthetics. Biochim Biophys Acta, 636:153–161. 1981.
ChenQ, CamaraAK, StoweDF, HoppelCL, LesnefskyEJ. Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion [Review]Am J Physiol Cell Physiol, 292:C137–C147. 2007.
114.
ChenQ, CrosbyM, AlmasanA. Redox regulation of apoptosis before and after cytochrome c release. Korean J Biol Sci, 7:1–9. 2003.
115.
ChenQ, LesnefskyEJ. Depletion of cardiolipin and cytochrome c during ischemia increases hydrogen peroxide production from the electron transport chain. Free Radic Biol Med, 40:976–982. 2006.
116.
ChenQ, MoghaddasS, HoppelCL, LesnefskyEJ. Reversible blockade of electron transport during ischemia protects mitochondria and decreases myocardial injury following reperfusion. J Pharmacol Exp Ther, 319:1405–1412. 2006.
117.
ChenQ, MoghaddasS, HoppelCL, LesnefskyEJ. Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. Am J Physiol Cell Physiol, 294:C460–C466. 2008.
118.
ChenQ, VazquezEJ, MoghaddasS, HoppelCL, LesnefskyEJ. Production of reactive oxygen species by mitochondria: Central role of complex III. J Biol Chem, 278:36027–36031. 2003.
119.
ChengQ, BosnjakZJ, KwokWM. Modulation of the mitochondrial VDAC by dephosphorylation and nitric oxide. Anesthesiology, 109:A1578. 2008.
120.
ChiaraF, CastellaroD, MarinO, PetronilliV, BrusilowWS, JuhaszovaM, SollottSJ, ForteM, BernardiP, RasolaA. Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels. PLoS ONE, 3:e1852. 2008.
CohenG, KeslerN. Monoamine oxidase inhibits mitochondrial respiration. Ann NY Acad Sci, 893:273–278. 1999.
126.
CohenMV, BainesCP, DowneyJM. Ischemic preconditioning: From adenosine receptor to KATP channel. Annu Rev Physiol, 62:79–109. 2000.
127.
ColingDE, YuKC, SomandD, SatarB, BaiU, HuangTT, SeidmanMD, EpsteinCJ, MhatreAN, LalwaniAK. Effect of SOD1 overexpression on age- and noise-related hearing loss. Free Radic Biol Med, 34:873–880. 2003.
128.
ConleyKE, MarcinekDJ, VillarinJ. Mitochondrial dysfunction and age. Curr Opin Clin Nutr Metab Care, 10:688–692. 2007.
129.
ContestabileA. Benefits of caloric restriction on brain aging and related pathological States: Understanding mechanisms to devise novel therapies. Curr Med Chem, 16:350–361. 2009.
130.
CooperJM, MannVM, SchapiraAH. Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: Effect of ageing. J Neurol Sci, 113:91–98. 1992.
131.
CoryS, AdamsJM. Killing cancer cells by flipping the Bcl-2/Bax switch. Cancer Cell, 8:5–6. 2005.
132.
CosentinoF, FranciaP, CamiciGG, PelicciPG, LuscherTF, VolpeM. Final common molecular pathways of aging and cardiovascular disease: Role of the p66Shc protein. Arterioscl Thromb Vasc Biol, 28:622–628. 2008.
CossuF, MastrangeloE, MilaniM, SorrentinoG, LecisD, DeliaD, ManzoniL, SeneciP, ScolasticoC, BolognesiM. Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2. Biochem Biophys Res Commun, 378:162–167. 2009.
135.
CostaAD, PierreSV, CohenMV, DowneyJM, GarlidKD. cGMP signalling in pre- and post-conditioning: The role of mitochondria. Cardiovasc Res, 77:344–352. 2008.
136.
CostantiniP, JacototE, DecaudinD, KroemerG. Mitochondrion as a novel target of anticancer chemotherapy. J Natl Cancer Inst, 92:1042–1053. 2000.
137.
CoudrayC, PucheuS, BoucherF, ArnaudJ, de LeirisJ, FavierA. Effect of ischemia/reperfusion sequence on cytosolic iron status and its release in the coronary effluent in isolated rat hearts. Biol Trace Elem Res, 41:69–75. 1994.
138.
CrabtreeGR. Calcium, calcineurin, and the control of transcription. J Biol Chem, 276:2313–2316. 2001.
139.
CromptonM, HedigerM, CarafoliE. The effect of inorganic phosphate on calcium influx into rat heart mitochondria. Biochem Biophys Res Commun, 80:540–546. 1978.
CromptonM, VirjiS, WardJM. Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. Eur J Biochem, 258:729–735. 1998.
da SilvaMM, SartoriA, BelisleE, KowaltowskiAJ. Ischemic preconditioning inhibits mitochondrial respiration, increases H2O2 release, and enhances K+ transport. Am J Physiol Heart Circ Physiol, 285:H154–H162. 2003.
144.
DaiY, LiuM, TangW, DeSanoJ, BursteinE, DavisM, PientaK, LawrenceT, XuL. Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis. Clin Cancer Res, 14:7701–7710. 2008.
145.
DaosukhoC, IttaratW, LinSM, SawyerDB, KininghamK, LieNYC, St ClairDK. Induction of manganese superoxide dismutase (MnSOD) mediates cardioprotective effect of tamoxifen (TAM)J Mol Cell Cardiol, 39:792–803. 2005.
146.
DarlingCE, JiangR, MaynardM, WhittakerP, Vinten–JohansenJ, PrzyklenkK. Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2. Am J Physiol Heart Circ Physiol, 289:H1618–H1626. 2005.
147.
DasKC, Lewis-MolockY, WhiteCW. Elevation of manganese superoxide dismutase gene expression by thioredoxin. Am J Respir Cell Mol Biol, 17:713–726. 1997.
148.
DashRK, BeardDA. Analysis of cardiac mitochondrial Na+-Ca2+ exchanger kinetics with a biophysical model of mitochondrial Ca2+ handling suggests a 3:1 stoichiometry. J Physiol, 586:3267–3285. 2008.
149.
DaveGS, KaliaK. Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy. Cell Mol Biol (Noisy-le-grand), 53:68–78. 2007.
150.
DaveKR, DeFazioRA, RavalAP, TorracoA, SaulI, BarrientosA, Perez–PinzonMA. Ischemic preconditioning targets the respiration of synaptic mitochondria via protein kinase C epsilon. J Neurosci, 28:4172–4182. 2008.
151.
de BritoOM, ScorranoL. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature, 456:605–610. 2008.
152.
de BritoOM, ScorranoL. Mitofusin 2: A mitochondria-shaping protein with signaling roles beyond fusion. Antioxid Redox Signal, 10:621–633. 2008.
153.
De GreyAD. HO2*: The forgotten radical. DNA Cell Biol, 21:251–257. 2002.
154.
DeierborgT, WielochT, DianoS, WardenCH, HorvathTL, MattiassonG. Overexpression of UCP2 protects thalamic neurons following global ischemia in the mouse. J Cereb Blood Flow Metab, 28:1186–1195. 2008.
155.
DengH, DodsonMW, HuangH, GuoM. The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc Natl Acad Sci USA, 105:14503–14508. 2008.
156.
DengJ, CarlsonN, TakeyamaK, Dal CinP, ShippM, LetaiA. BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents. Cancer Cell, 12:171–185. 2007.
157.
DernekS, IkizlerM, ErkasapN, ErgunB, KokenT, YilmazK, SevinB, KaygisizZ, KuralT. Cardioprotection with resveratrol pretreatment: Improved beneficial effects over standard treatment in rat hearts after global ischemia. Scand Cardiovasc J, 38:245–254. 2004.
158.
DesoukiMM, KulawiecM, BansalS, DasGM, SinghKK. Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors. Cancer Biol Ther, 4:1367–1373. 2005.
159.
DeviL, PrabhuBM, GalatiDF, AvadhaniNG, AnandatheerthavaradaHK. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci, 26:9057–9068. 2006.
160.
Di LisaF, BernardiP. Mitochondrial function as a determinant of recovery or death in cell response to injury. Mol Cell Biochem, 184:379–391. 1998.
161.
Di LisaF, BernardiP. Mitochondria and ischemia-reperfusion injury of the heart: Fixing a hole. Cardiovasc Res, 70:191–199. 2006.
162.
Di LisaF, MenaboR, CantonM, PetronilliV. The role of mitochondria in the salvage and the injury of the ischemic myocardium. Biochim Biophys Acta, 1366:69–78. 1998.
163.
Di LorenzoC, PierelliF, CoppolaG, GriecoGS, RengoC, CiccolellaM, MagisD, BollaM, CasaliC, SantorelliFM, SchoenenJ. Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs. Neurology, 72:1588–1594. 2009.
164.
Di VizioD, SolomonKR, FreemanMR. Cholesterol and cholesterol-rich membranes in prostate cancer: An update. Tumori, 94:633–639. 2008.
165.
DiMauroS. Mitochondrial DNA medicine. Biosci Rep, 27:5–9. 2007.
166.
DiMauroS, SchonEA. Mitochondrial disorders in the nervous system. Annu Rev Neurosci, 31:91–123. 2008.
DobsakP, SiegelovaJ, WolfJE, RochetteL, EicherJC, VaskuJ, KuchtickovaS, HorkyM. Prevention of apoptosis by deferoxamine during 4 hours of cold cardioplegia and reperfusion: In vitro study of isolated working rat heart model. Pathophysiology, 9:27. 2002.
170.
DoctrowSR, HuffmanK, MarcusCB, ToccoG, MalfroyE, AdinolfiCA, KrukH, BakerK, LazarowychN, MascarenhasJ, MalfroyB. Salen-manganese complexes as catalytic scavengers of hydrogen peroxide and cytoprotective agents: Structure-activity relationship studies. J Med Chem, 45:4549–4558. 2002.
171.
DoenstT, BuggerH, SchwarzerM, FaerberG, BorgerMA, MohrFW. Three good reasons for heart surgeons to understand cardiac metabolism. Eur J Cardiothorac Surg, 33:862–871. 2008.
172.
DoonanR, McElweeJJ, MatthijssensF, WalkerGA, HouthoofdK, BackP, MatscheskiA, VanfleterenJR, GemsD. Against the oxidative damage theory of aging: Superoxide dismutases protect against oxidative stress but have little or no effect on life span in Caenorhabditis elegans. Genes Dev, 22:3236–3241. 2008.
173.
Dos SantosP, KowaltowskiAJ, LaclauMN, SeetharamanS, PaucekP, BoudinaS, ThamboJB, TariosseL, GarlidKD. Mechanisms by which opening the mitochondrial ATP-sensitive K+ channel protects the ischemic heart. Am J Physiol Heart Circ Physiol, 283:H284–H295. 2002.
DuC, FangM, LiY, LiL, WangX. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell, 102:33–42. 2000.
176.
DuW, LiW, ChenG, CaoH, TangH, TangX, JinQ, SunZ, ZhaoH, ZhouW, HeS, LvY, ZhaoJ, ZhangX. Detection of known base substitution mutations in human mitochondrial DNA of MERRF and MELAS by biochip technology. Biosens Bioelectron, 24:2371–2376. 2009.
177.
DuchenMR. Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol Aspects Med, 25:365–451. 2004.
178.
DuvoisinRC. Genetic and environmental factors in Parkinson's disease. Adv Neurol, 80:161–163. 1999.
179.
DykensJA, WillY. The significance of mitochondrial toxicity testing in drug development. Drug Discov Today, 12:777–785. 2007.
180.
EbrahimianT, SairamMR, SchiffrinEL, TouyzRM. Cardiac hypertrophy is associated with altered thioredoxin and ASK-1 signaling in a mouse model of menopause. Am J Physiol Heart Circ Physiol, 295:H1481–H1488. 2008.
181.
EbrahimianT, TouyzRM. Thioredoxin in vascular biology: Role in hypertension. Antioxid Redox Signal, 10:1127–1136. 2008.
182.
EchtayKS, EstevesTC, PakayJL, JekabsonsMB, LambertAJ, Portero–OtinM, PamplonaR, Vidal–PuigAJ, WangS, RoebuckSJ, BrandMD. A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J, 22:4103–4110. 2003.
183.
ElchuriS, OberleyTD, QiW, EisensteinRS, Jackson RobertsL, Van RemmenH, EpsteinCJ, HuangTT. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene, 24:367–380. 2005.
184.
EsperRJ, VilarinoJO, MachadoRA, ParaganoA. Endothelial dysfunction in normal and abnormal glucose metabolism. Adv Cardiol, 45:17–43. 2008.
185.
FengJ, ZhuM, SchaubMC, GehrigP, RoschitzkiB, LucchinettiE, ZauggM. Phosphoproteome analysis of isoflurane-protected heart mitochondria: phosphorylation of adenine nucleotide translocator-1 on Tyr194 regulates mitochondrial function. Cardiovasc Res, 80:20–29. 2008.
186.
FennellJP, BrosnanMJ, FraterAJ, HamiltonCA, AlexanderMY, NicklinSA, HeistadDD, BakerAH, DominiczakAF. Adenovirus-mediated overexpression of extracellular superoxide dismutase improves endothelial dysfunction in a rat model of hypertension. Gene Ther, 9:110–117. 2002.
187.
FerdinandyP, SchulzR. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol, 138:532–543. 2003.
188.
FiskumG, RosenthalRE, VereczkiV, MartinE, HoffmanGE, ChinopoulosC, KowaltowskiA. Protection against ischemic brain injury by inhibition of mitochondrial oxidative stress. J Bioenerg Biomembr, 36:347–352. 2004.
189.
FlanaganSW, AndersonRD, RossMA, OberleyLW. Overexpression of manganese superoxide dismutase attenuates neuronal death in human cells expressing mutant (G37R) Cu/Zn-superoxide dismutase. J Neurochem, 81:170–177. 2002.
190.
Fontan–LozanoA, Lopez–LluchG, Delgado–GarciaJM, NavasP, CarrionAM. Molecular bases of caloric restriction regulation of neuronal synaptic plasticity. Mol Neurobiol, 38:167–177. 2008.
191.
FriehsI, MoranAM, StammC, ColanSD, TakeuchiK, Cao–DanhH, RaderCM, McGowanFX, del NidoPJ. Impaired glucose transporter activity in pressure-overload hypertrophy is an early indicator of progression to failure. Circulation, 100:II187–II193. 1999.
192.
FrolkisVV, FrolkisRA, MkhitarianLS, FraifeldVE. Age-dependent effects of ischemia and reperfusion on cardiac function and Ca2+ transport in myocardium. Gerontology, 37:233–239. 1991.
193.
FruehaufJP, MeyskensFLJr.Reactive oxygen species: A breath of life or death?Clin Cancer Res, 13:789–794. 2007.
194.
GaliegueS, TinelN, CasellasP. The peripheral benzodiazepine receptor: a promising therapeutic drug target. Curr Med Chem, 10:1563–1572. 2003.
195.
GalluzziL, KeppO, TajeddineN, KroemerG. Disruption of the hexokinase-VDAC complex for tumor therapy. Oncogene, 27:4633–4635. 2008.
196.
GalluzziL, LarochetteN, ZamzamiN, KroemerG. Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene, 25:4812–4830. 2006.
197.
GalluzziL, MorselliE, KeppO, KroemerG. Targeting post-mitochondrial effectors of apoptosis for neuroprotection. Biochim Biophys Acta, 1787:402–413. 2009.
198.
GanoteCE, WorstellJ, KaltenbachJP. Oxygen-induced enzyme release after irreversible myocardial injury. Effects of cyanide in perfused rat hearts. Am J Pathol, 84:327–350. 1976.
199.
GardnerPR, RaineriI, EpsteinLB, WhiteCW. Superoxide radical and iron modulate aconitase activity in mammalian cells. J Biol Chem, 270:13399–13405. 1995.
200.
GarlidKD. Opening mitochondrial KATP in the heart—What happens, and what does not happen. Basic Res Cardiol, 95:275–279. 2000.
201.
GarlidKD, Dos SantosP, XieZJ, CostaAD, PaucekP. Mitochondrial potassium transport: The role of the mitochondrial ATP-sensitive K+ channel in cardiac function and cardioprotection. Biochim Biophys Acta, 1606:1–21. 2003.
GarnierA, FortinD, DelomenieC, MomkenI, VekslerV, Ventura–ClapierR. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol, 551:491–501. 2003.
204.
GarridoC, GalluzziL, BrunetM, PuigPE, DidelotC, KroemerG. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ, 13:1423–1433. 2006.
205.
GazittY, FeyV, ThomasC, AlvarezR. Bcl-2 overexpression is associated with resistance to dexamethasone, but not melphalan, in multiple myeloma cells. Int J Oncol, 13:397–405. 1998.
206.
GenovaML, VenturaB, GiulianoG, BovinaC, FormigginiG, Parenti CastelliG, LenazG. The site of production of superoxide radical in mitochondrial Complex I is not a bound ubisemiquinone but presumably iron-sulfur cluster N2. FEBS Lett, 505:364–368. 2001.
207.
GerichFJ, HeppS, ProbstI, MullerM. Mitochondrial inhibition prior to oxygen-withdrawal facilitates the occurrence of hypoxia-induced spreading depression in rat hippocampal slices. J Neurophysiol, 96:492–504. 2006.
GhoshJC, AltieriDC. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells. Clin Cancer Res, 11:4580–4588. 2005.
211.
GiorgioM, MigliaccioE, OrsiniF, PaolucciD, MoroniM, ContursiC, PellicciaG, LuziL, MinucciS, MarcaccioM, PintonP, RizzutoR, BernardiP, PaolucciF, PelicciPG. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell, 122:221–233. 2005.
212.
GogvadzeV, OrreniusS, ZhivotovskyB. Mitochondria as targets for cancer chemotherapy. Semin Cancer Biol, 19:57–66. 2009.
GorbunovNV, YalowichJC, GaddamA, ThampattyP, RitovVB, KisinER, ElsayedNM, KaganVE. Nitric oxide prevents oxidative damage produced by tert-butyl hydroperoxide in erythroleukemia cells via nitrosylation of heme and non-heme iron. Electron paramagnetic resonance evidence. J Biol Chem, 272:12328–12341. 1997.
216.
Grasbon–FrodlEM, KoselS, RiessO, MullerU, MehraeinP, GraeberMB. Analysis of mitochondrial targeting sequence and coding region polymorphisms of the manganese superoxide dismutase gene in German Parkinson disease patients. Biochem Biophys Res Commun, 255:749–752. 1999.
217.
GreenDR. Apoptotic pathways: The roads to ruin. Cell, 94:695–698. 1998.
218.
GreenK, BrandMD, MurphyMP. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes, 53,Suppl 1:S110–S118. 2004.
219.
GriendlingKK, SorescuD, Ushio–FukaiM. NAD(P)H oxidase: Role in cardiovascular biology and disease. Circ Res, 86:494–501. 2000.
220.
GrigorieffN. Structure of the respiratory NADH:ubiquinone oxidoreductase (complex I)Curr Opin Struct Biol, 9:476–483. 1999.
221.
GrishkoV, SolomonM, WilsonGL, LeDouxSP, GillespieMN. Oxygen radical-induced mitochondrial DNA damage and repair in pulmonary vascular endothelial cell phenotypes. Am J Physiol Lung Cell Mol Physiol, 280:L1300–L1308. 2001.
222.
GrollmanAP, MoriyaM. Mutagenesis by 8-oxoguanine: An enemy within. Trends Genet, 9:246–249. 1993.
223.
GrossGJ, PeartJN. Opioids and myocardial reperfusion injury. Arch Mal Coeur Vaiss, 100:231–237. 2007.
GuillonB, BulteauAL, Wattenhofer–DonzeM, SchmuckerS, FriguetB, PuccioH, DrapierJC, BoutonC. Frataxin deficiency causes upregulation of mitochondrial Lon and ClpP proteases and severe loss of mitochondrial Fe-S proteins. FEBS J, 276:1036–1047. 2009.
226.
GunterTE, ChaceJH, PuskinJS, GunterKK. Mechanism of sodium independent calcium efflux from rat liver mitochondria. Biochemistry, 22:6341–6351. 1983.
227.
GunterTE, GunterKK, SheuSS, GavinCE. Mitochondrial calcium transport: Physiological and pathological relevance. Am J Physiol, 267:C313–C339. 1994.
228.
GursahaniHI, SchaeferS. Acidification reduces mitochondrial calcium uptake in rat cardiac mitochondria. Am J Physiol Heart Circ Physiol, 287:H2659–H665. 2004.
229.
GustafssonAB, GottliebRA. Bcl-2 family members and apoptosis, taken to heart. Am J Physiol Cell Physiol, 292:C45–C51. 2007.
230.
GutteridgeJM. Superoxide-dependent formation of hydroxyl radicals from ferric-complexes and hydrogen peroxide: An evaluation of fourteen iron chelators. Free Rad Res Comm, 9:119–125. 1990.
231.
Gyrd-HansenM, DardingM, MiasariM, SantoroMM, ZenderL, XueW, TenevT, da FonsecaPC, ZvelebilM, BujnickiJM, LoweS, SilkeJ, MeierP. IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis. Nat Cell Biol, 10:1309–1317. 2008.
232.
HaasRH, ParikhS, FalkMJ, SanetoRP, WolfNI, DarinN, CohenBH. Mitochondrial disease: A practical approach for primary care physicians. Pediatrics, 120:1326–1333. 2007.
233.
HachmeisterJE, ValluruL, BaoF, LiuD. Mn (III) tetrakis (4-benzoic acid) porphyrin administered into the intrathecal space reduces oxidative damage and neuron death after spinal cord injury: A comparison with methylprednisolone. J Neurotrauma, 23:1766–1778. 2006.
234.
HagenTM, WehrCM, AmesBN. Mitochondrial decay in aging. Reversal through supplementation of acetyl-L-carnitine and N-tert-butyl-alpha-phenyl-nitrone. Ann NY Acad Sci, 854:214–223. 1998.
235.
HailNJr.Mitochondrial reactive oxygen species affect sensitivity to curcumin-induced apoptosis. Free Radic Biol Med, 44:1382–1393. 2008.
236.
HalestrapAP, ClarkeSJ, JavadovSA. Mitochondrial permeability transition pore opening during myocardial reperfusion—A target for cardioprotection. Cardiovasc Res, 61:372–385. 2004.
237.
HalestrapAP, ClarkeSJ, KhaliulinI. The role of mitochondria in protection of the heart by preconditioning. Biochim Biophys Acta, 1767:1007–1031. 2007.
238.
Hamacher-BradyA, BradyNR, LogueSE, SayenMR, JinnoM, KirshenbaumLA, GottliebRA, GustafssonAB. Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ, 14:146–157. 2007.
239.
HamiltonBF, StokesAH, LyonJ, AdlerRR. In vivo assessment of mitochondrial toxicity. Drug Discov Today, 13:785–790. 2008.
240.
HanD, CanaliR, RettoriD, KaplowitzN. Effect of glutathione depletion on sites and topology of superoxide and hydrogen peroxide production in mitochondria. Mol Pharmacol, 64:1136–1144. 2003.
241.
HanJ, KimN, KimE, HoWK, EarmYE. Modulation of ATP-sensitive potassium channels by cGMP-dependent protein kinase in rabbit ventricular myocytes. J Biol Chem, 276:22140–22147. 2001.
242.
HandschinC, SpiegelmanBM. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature, 454:463–469. 2008.
243.
HanleyPJ, DautJ. KATP channels and preconditioning: A re-examination of the role of mitochondrial KATP channels and an overview of alternative mechanisms. J Mol Cell Cardiol, 39:17–50. 2005.
244.
HanleyPJ, GopalanKV, LareauRA, SrivastavaDK, von MeltzerM, DautJ. Beta-oxidation of 5-hydroxydecanoate, a putative blocker of mitochondrial ATP-sensitive potassium channels. J Physiol, 547:387–393. 2003.
245.
HanleyPJ, MickelM, LofflerM, BrandtU, DautJ. KATP channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol, 542:735–741. 2002.
246.
HanleyPJ, RayJ, BrandtU, DautJ. Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria. J Physiol, 544:687–693. 2002.
247.
Hansson PetersenCA, AlikhaniN, BehbahaniH, WiehagerB, PavlovPF, AlafuzoffI, LeinonenV, ItoA, WinbladB, GlaserE, AnkarcronaM. The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc Natl Acad Sci USA, 105:13145–13150. 2008.
248.
HanukogluI, RapoportR. Routes and regulation of NADPH production in steroidogenic mitochondria. Endoc Res, 21:231–241. 1995.
HaumannJA, HeisnerM, JSStowe, DF, CamaraAKS. Hypothermia impedes calcium induced mitochondrial permeability transition pore opening in mitochondria harvested after cold ischemia of isolated hearts. FASEB J, 508:4pos. 2009.
251.
HausenloyDJ, MaddockHL, BaxterGF, YellonDM. Inhibiting mitochondrial permeability transition pore opening: A new paradigm for myocardial preconditioning?Cardiovasc Res, 55:534–543. 2002.
252.
HeM, CaiJ, GoYM, JohnsonJM, MartinWD, HansenJM, JonesDP. Identification of thioredoxin-2 as a regulator of the mitochondrial permeability transition. Toxicol Sci, 105:44–50. 2008.
253.
HeinenA, CamaraAK, AldakkakM, RhodesSS, RiessML, StoweDF. Mitochondrial Ca2+-induced K+ influx increases respiration and enhances ROS production while maintaining membrane potential. Am J Physiol Cell Physiol, 292:C148–C156. 2007.
254.
HenchcliffeC, BealMF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol, 4:600–609. 2008.
255.
HeppleRT, BakerDJ, McConkeyM, MurynkaT, NorrisR. Caloric restriction protects mitochondrial function with aging in skeletal and cardiac muscles. Rejuvenation Res, 9:219–222. 2006.
256.
HetzC, ThielenP, FisherJ, PasinelliP, BrownRH, KorsmeyerS, GlimcherL. The proapoptotic BCL-2 family member BIM mediates motoneuron loss in a model of amyotrophic lateral sclerosis. Cell Death Differ, 14:1386–1389. 2007.
HirrlingerJ, GuttererJM, KussmaulL, HamprechtB, DringenR. Microglial cells in culture express a prominent glutathione system for the defense against reactive oxygen species. Dev Neurosci, 22:384–392. 2000.
259.
HoYS, XiongY, MaW, SpectorA, HoDS. Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J Biol Chem, 279:32804–32812. 2004.
260.
HojlundK, WrzesinskiK, LarsenPM, FeySJ, RoepstorffP, HandbergA, DelaF, VintenJ, McCormackJG, ReynetC, Beck–NielsenH. Proteome analysis reveals phosphorylation of ATP synthase beta-subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes. J Biol Chem, 278:10436–10442. 2003.
261.
HondaHM, KorgeP, WeissJN. Mitochondria and ischemia/reperfusion injury. Ann NY Acad Sci, 1047:248–258. 2005.
HuangTT, CarlsonEJ, GillespieAM, ShiY, EpsteinCJ. Ubiquitous overexpression of CuZn superoxide dismutase does not extend life span in mice. J Gerontol A Biol Sci Med Sci, 55:B5–B9. 2000.
264.
HuangTT, CarlsonEJ, KozyHM, ManthaS, GoodmanSI, UrsellPC, EpsteinCJ. Genetic modification of prenatal lethality and dilated cardiomyopathy in Mn superoxide dismutase mutant mice. Free Radic Biol Med, 31:1101–1110. 2001.
265.
ImotoK, KukidomeD, NishikawaT, MatsuhisaT, SonodaK, FujisawaK, YanoM, MotoshimaH, TaguchiT, TsuruzoeK, MatsumuraT, IchijoH, ArakiE. Impact of mitochondrial reactive oxygen species and apoptosis signal-regulating kinase 1 on insulin signaling. Diabetes, 55:1197–1204. 2006.
266.
InarreaP, MoiniH, HanD, RettoriD, AguiloI, AlavaMA, IturraldeM, CadenasE. Mitochondrial respiratory chain and thioredoxin reductase regulate intermembrane Cu,Zn-superoxide dismutase activity: Implications for mitochondrial energy metabolism and apoptosis. Biochem J, 405:173–179. 2007.
267.
IngwallJS, WeissRG. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res, 95:135–145. 2004.
268.
IshitsukaK, HideshimaT, HamasakiM, RajeN, KumarS, PodarK, Le GouillS, ShiraishiN, YasuiH, RoccaroAM, TaiYZ, ChauhanD, FramR, TamuraK, JainJ, AndersonKC. Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathway. Oncogene, 24:5888–5896. 2005.
269.
JangJY, ChoiY, JeoNYK, AungKC, KimCW. Over-expression of adenine nucleotide translocase 1 (ANT1) induces apoptosis and tumor regression in vivo. BMC Cancer, 8:160. 2008.
270.
JavadovS, ChoiA, RajapurohitamV, ZeidanA, BasnakianAG, KarmazynM. NHE-1 inhibition-induced cardioprotection against ischaemia/reperfusion is associated with attenuation of the mitochondrial permeability transition. Cardiovasc Res, 77:416–424. 2008.
271.
JavadovS, HuangC, KirshenbaumL, KarmazynM. NHE-1 inhibition improves impaired mitochondrial permeability transition and respiratory function during postinfarction remodelling in the rat. J Mol Cell Cardiol, 38:135–143. 2005.
272.
JavadovS, PurdhamDM, ZeidanA, KarmazynM. NHE-1 inhibition improves cardiac mitochondrial function through regulation of mitochondrial biogenesis during postinfarction remodeling. Am J Physiol Heart Circ Physiol, 291:H1722–H1730. 2006.
273.
JavadovSA, ClarkeS, DasM, GriffithsEJ, LimKH, HalestrapAP. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol, 549:513–524. 2003.
JinZQ, ZhouHZ, CecchiniG, GrayMO, KarlinerJS. MnSOD in mouse heart: acute responses to ischemic preconditioning and ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol, 288:H2986–H2994. 2005.
276.
JonesNA, TurnerJ, McIlwrathAJ, BrownR, DiveC. Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53. Mol Pharmacol, 53:819–826. 1998.
KasamakiY, GuoAC, McDonaldTF. Protection by hypoxic preconditioning against hypoxia-reoxygenation injury in guinea-pig papillary muscles. Cardiovasc Res, 34:313–322. 1997.
283.
KawataH, YoshidaK, KawamotoA, KuriokaH, TakaseE, SasakiY, HatanakaK, KobayashiM, UeyamaT, HashimotoT, DohiK. Ischemic preconditioning upregulates vascular endothelial growth factor mRNA expression and neovascularization via nuclear translocation of protein kinase C epsilon in the rat ischemic myocardium. Circ Res, 88:696–704. 2001.
284.
KeepM, ElmerE, FongKS, CsiszarK. Intrathecal cyclosporin prolongs survival of late-stage ALS mice. Brain Res, 894:327–331. 2001.
285.
KellyM, LacourB, Nguyen–KhoaT. Dysregulation of superoxide dismutase in chronic kidney disease. Nephron Clin Pract, 100:c103–c104. 2005.
286.
KelsoGF, PorteousCM, CoulterCV, HughesG, PorteousWK, LedgerwoodEC, SmithRA, MurphyMP. Selective targeting of a redox-active ubiquinone to mitochondria within cells: Antioxidant and antiapoptotic properties. J Biol Chem, 276:4588–4596. 2001.
287.
KerendiF, KinH, HalkosME, JiangR, ZattaAJ, ZhaoZQ, GuytonRA, Vinten–JohansenJ. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors. Basic Res Cardiol, 100:404–412. 2005.
288.
KernerJ, ZaluzecE, GageD, BieberLL. Characterization of the malonyl-CoA-sensitive carnitine palmitoyltransferase (CPTo) of a rat heart mitochondrial particle. Evidence that the catalytic unit is CPTi. J Biol Chem, 269:8209–8219. 1994.
289.
KevinLG, CamaraAK, RiessML, NovalijaE, StoweDF. Ischemic preconditioning alters real-time measure of O2 radicals in intact hearts with ischemia and reperfusion. Am J Physiol Heart Circ Physiol, 284:H566–H574. 2003.
290.
KevinLG, NovalijaE, RiessML, CamaraAK, RhodesSS, StoweDF. Sevoflurane exposure generates superoxide but leads to decreased superoxide during ischemia and reperfusion in isolated hearts. Anesth Analg, 96:949–955. 2003.
291.
KhaliulinI, ClarkeSJ, LinH, ParkerJ, SuleimanMS, HalestrapAP. Temperature preconditioning of isolated rat hearts—A potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mitochondrial permeability transition pore. J Physiol, 581:1147–1161. 2007.
292.
KhrapkoK, VijgJ. Mitochondrial DNA mutations and aging: Devils in the details?Trends Genet, 25:91–98. 2009.
293.
KienhoferJ, HausslerDJ, RuckelshausenF, MuessigE, WeberK, PimentelD, UllrichV, BurkleA, BachschmidMM. Association of mitochondrial antioxidant enzymes with mitochondrial DNA as integral nucleoid constituents. FASEB J, 23:2034–2044. 2009.
294.
KimA, MurphyMP, OberleyTD. Mitochondrial redox state regulates transcription of the nuclear-encoded mitochondrial protein manganese superoxide dismutase: A proposed adaptive response to mitochondrial redox imbalance. Free Radic Biol Med, 38:644–654. 2005.
295.
KimGT, ChuNYS, ParkJW, KimMS. Role of apoptosis-inducing factor in myocardial cell death by ischemia-reperfusion. Biochem Biophys Res Commun, 309:619–624. 2003.
KimJS, HeL, LemastersJJ. Mitochondrial permeability transition: A common pathway to necrosis and apoptosis. Biochem Biophys Res Commun, 304:463–470. 2003.
298.
KimYM, BombeckCA, BilliarTR. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res, 84:253–256. 1999.
299.
KimuraS, ZhangGX, NishiyamaA, ShokojiT, YaoL, FaNYY, RahmanM, SuzukiT, MaetaH, AbeY. Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II. Hypertension, 45:860–866. 2005.
KindlerDD, ThiffaultC, SolenskiNJ, DennisJ, KosteckiV, JenkinsR, KeeneyPM, BennettJPJr.Neurotoxic nitric oxide rapidly depolarizes and permeabilizes mitochondria by dynamically opening the mitochondrial transition pore. Mol Cell Neurosci, 23:559–573. 2003.
302.
KirkinezosIG, BacmanSR, HernandezD, Oca–CossioJ, AriasLJ, Perez–PinzonMA, BradleyWG, MoraesCT. Cytochrome c association with the inner mitochondrial membrane is impaired in the CNS of G93A-SOD1 mice. J Neurosci, 25:164–172. 2005.
303.
KlamannA, SarfertP, LaunhardtV, SchulteG, SchmiegelWH, NauckMA. Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide)Eur Heart J, 21:220–229. 2000.
KoehlerCM. Protein translocation pathways of the mitochondrion. FEBS Lett, 476:27–31. 2000.
306.
KogaY, NataliyaP. [Migraine headache and mitochondrial DNA abnormality]. Nippon Rinsho. Jpn J Clin Med, 63:1720–1726. 2005.
307.
KorgeP, HondaHM, WeissJN. K+-dependent regulation of matrix volume improves mitochondrial function under conditions mimicking ischemia-reperfusion. Am J Physiol Heart Circ Physiol, 289:H66–H77. 2005.
308.
KornmannB, CurrieE, CollinsSR, SchuldinerM, NunnariJ, WeissmanJS, WalterP. An ER-mitochondria tethering complex revealed by a synthetic biology screen. Science, 325:477–481. 2009.
309.
KorshunovSS, SkulachevVP, StarkovAA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett, 416:15–18. 1997.
310.
KoutnikovaH, CampuzanoV, FouryF, DolleP, CazzaliniO, KoenigM. Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat Genet, 16:345–351. 1997.
KukatA, KukatC, BrocherJ, SchaferI, KrohneG, TrounceIA, VillaniG, SeibelP. Generation of rho0 cells utilizing a mitochondrially targeted restriction endonuclease and comparative analyses. Nucleic Acids Res, 36:e44. 2008.
313.
KungLC, ChanSH, WuKL, OuCC, TaiMH, ChanJY. Mitochondrial respiratory enzyme complexes in rostral ventrolateral medulla as cellular targets of nitric oxide and superoxide interaction in the antagonism of antihypertensive action of eNOS transgene. Mol Pharmacol, 74:1319–1332. 2008.
314.
KwongJQ, HenningMS, StarkovAA, ManfrediG. The mitochondrial respiratory chain is a modulator of apoptosis. J Cell Biol, 179:1163–1177. 2007.
315.
LabiV, GrespiF, BaumgartnerF, VillungerA. Targeting the Bcl-2-regulated apoptosis pathway by BH3 mimetics: a breakthrough in anticancer therapy?Cell Death Differ, 15:977–987. 2008.
316.
LambertAJ, BrandMD. Inhibitors of the quinone-binding site allow rapid superoxide production from mitochondrial NADH:ubiquinone oxidoreductase (complex I)J Biol Chem, 279:39414–39420. 2004.
317.
LambertAJ, BrandMD. Superoxide production by NADH:ubiquinone oxidoreductase (complex I) depends on the pH gradient across the mitochondrial inner membrane. Biochem J, 382:511–517. 2004.
LautamakiR, AiraksinenKE, SeppanenM, ToikkaJ, LuotolahtiM, BallE, BorraR, HarkonenR, IozzoP, StewartM, KnuutiJ, NuutilaP. Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease: A 16-week randomized, double-blind, placebo-controlled study. Diabetes, 54:2787–2794. 2005.
320.
LawrenceJW, ClaireDC, WeissigV, RoweTC. Delayed cytotoxicity and cleavage of mitochondrial DNA in ciprofloxacin-treated mammalian cells. Mol Pharmacol, 50:1178–1188. 1996.
321.
LebovitzRM, ZhangH, VogelH, CartwrightJJr., DionneL, LuN, HuangS, MatzukMM. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci USA, 93:9782–9787. 1996.
322.
LeeBH, SeoHW, YiKY, LeeS, LeeS, YooSE. Effects of KR-32570, a new Na+/H+ exchanger inhibitor, on functional and metabolic impairments produced by global ischemia and reperfusion in the perfused rat heart. Eur J Pharmacol, 511:175–182. 2005.
323.
LenkaN, VijayasarathyC, MullickJ, AvadhaniNG. Structural organization and transcription regulation of nuclear genes encoding the mammalian cytochrome c oxidase complex. Prog Nucleic Acid Res Mol Biol, 61:309–344. 1998.
324.
LesnefskyEJ, ChenQ, MoghaddasS, HassanMO, TandlerB, HoppelCL. Blockade of electron transport during ischemia protects cardiac mitochondria. J Biol Chem, 279:47961–47967. 2004.
325.
LesnefskyEJ, ChenQ, SlabeTJ, StollMS, MinklerPE, HassanMO, TandlerB, HoppelCL. Ischemia, rather than reperfusion, inhibits respiration through cytochrome oxidase in the isolated, perfused rabbit heart: Role of cardiolipin. Am J Physiol Heart Circ Physiol, 287:H258–H267. 2004.
326.
LesnefskyEJ, GalloDS, YeJ, WhittinghamTS, LustWD. Aging increases ischemia-reperfusion injury in the isolated, buffer-perfused heart. J Lab Clin Med, 124:843–851. 1994.
327.
LesnefskyEJ, GudzTI, MigitaCT, Ikeda-SaitoM, HassanMO, TurkalyPJ, HoppelCL. Ischemic injury to mitochondrial electron transport in the aging heart: Damage to the iron-sulfur protein subunit of electron transport complex III. Arch Biochem Biophys, 385:117–128. 2001.
328.
LesnefskyEJ, GudzTI, MoghaddasS, MigitaCT, Ikeda–SaitoM, TurkalyPJ, HoppelCL. Aging decreases electron transport complex III activity in heart interfibrillar mitochondria by alteration of the cytochrome c binding site. J Mol Cell Cardiol, 33:37–47. 2001.
329.
LesnefskyEJ, HeD, MoghaddasS, HoppelCL. Reversal of mitochondrial defects before ischemia protects the aged heart. FASEB J, 20:1543–1535. 2006.
LetaiAG. Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nat Rev Cancer, 8:121–132. 2008.
334.
LevyRJ, DeutschmanCS. Deficient mitochondrial biogenesis in critical illness: Cause, effect, or epiphenomenon?Crit Care, 11:158. 2007.
335.
LiJ, FengQ, KimJM, SchneidermanD, ListonP, LiM, VanderhydenB, FaughtW, FungMF, SentermanM, KornelukRG, TsangBK. Human ovarian cancer and cisplatin resistance: Possible role of inhibitor of apoptosis proteins. Endocrinology, 142:370–380. 2001.
336.
LiLY, LuoX, WangX. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature, 412:95–99. 2001.
337.
LiQ, SatoEF, KiraY, NishikawaM, UtsumiK, InoueM. A possible cooperation of SOD1 and cytochrome c in mitochondria-dependent apoptosis. Free Radic Biol Med, 40:173–181. 2006.
338.
LiS, YanT, YangJQ, OberleyTD, OberleyLW. The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res, 60:3927–3939. 2000.
339.
LiTF, LuoYM, LuCZ. [The expression of Smac and XIAP in rat hippocampus following limbic seizure induced by kainic acid injection into amygdaloid nucleus]Sheng Li Xue Bao, 56:172–177. 2004.
LiY, JohnsonN, CapanoM, EdwardsM, CromptonM. Cyclophilin-D promotes the mitochondrial permeability transition but has opposite effects on apoptosis and necrosis. Biochem J, 383:101–109. 2004.
342.
LiY, MaedlerK, ShuL, HaatajaL. UCP-2 and UCP-3 proteins are differentially regulated in pancreatic beta-cells. PLoS ONE, 3:e1397. 2008.
343.
LiachenkoS, TangP, XuY. Deferoxamine improves early postresuscitation reperfusion after prolonged cardiac arrest in rats. J Cereb Blood Flow Metab, 23:574–581. 2003.
344.
LiangH, WardWF. PGC-1alpha: A key regulator of energy metabolism. Adv Physiol Educ, 30:145–151. 2006.
345.
LinMT, BealMF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature, 443:787–795. 2006.
346.
LiuSS. Cooperation of a "reactive oxygen cycle" with the Q cycle and the proton cycle in the respiratory chain–superoxide generating and cycling mechanisms in mitochondria. J Bioenerg Biomembr, 31:367–376. 1999.
347.
LiuY, FiskumG, SchubertD. Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neurochem, 80:780–787. 2002.
348.
LoebLA, WallaceDC, MartinGM. The mitochondrial theory of aging and its relationship to reactive oxygen species damage and somatic mtDNA mutations. Proc Natl Acad Sci USA, 102:18769–18770. 2005.
349.
LucasDT, SzwedaLI. Cardiac reperfusion injury: Aging, lipid peroxidation, and mitochondrial dysfunction. Proc Natl Acad Sci USA, 95:510–514. 1998.
350.
LundbergKC, SzwedaLI. Preconditioning prevents loss in mitochondrial function and release of cytochrome c during prolonged cardiac ischemia/reperfusion. Arch Biochem Biophys, 453:130–134. 2006.
351.
LuptakI, YanJ, CuiL, JainM, LiaoR, TianR. Long-term effects of increased glucose entry on mouse hearts during normal aging and ischemic stress. Circulation, 116:901–909. 2007.
352.
MaassenJA. Mitochondrial dysfunction in adipocytes: The culprit in type 2 diabetes?Diabetologia, 49:619–620. 2006.
353.
MacDonaldMJ, LongacreMJ, LangbergEC, TibellA, KendrickMA, FukaoT, OstensonCG. Decreased levels of metabolic enzymes in pancreatic islets of patients with type 2 diabetes. Diabetologia, 52:1087–1091. 2009.
MandicA, ViktorssonK, MolinM, AkusjarviG, EguchiH, HayashiSI, ToiM, HanssonJ, LinderS, ShoshanMC. Cisplatin induces the proapoptotic conformation of Bak in a deltaMEKK1-dependent manner. Mol Cell Biol, 21:3684–3691. 2001.
359.
MandicA, ViktorssonK, StrandbergL, HeidenT, HanssonJ, LinderS, ShoshanMC. Calpain-mediated Bid cleavage and calpain-independent Bak modulation: Two separate pathways in cisplatin-induced apoptosis. Mol Cell Biol, 22:3003–3013. 2002.
360.
MansillaF, da CostaKA, WangS, KruhofferM, LewinTM, OrntoftTF, ColemanRA, Birkenkamp–DemtroderK. Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer. J Mol Med, 87:85–97. 2009.
361.
MarianiJ, OuR, BaileyM, RowlandM, NagleyP, RosenfeldtF, PepeS. Tolerance to ischemia and hypoxia is reduced in aged human myocardium. J Thorac Cardiovasc Surg, 120:660–667. 2000.
362.
MartelliA, Wattenhofer–DonzeM, SchmuckerS, BouvetS, ReutenauerL, PuccioH. Frataxin is essential for extramitochondrial Fe-S cluster proteins in mammalian tissues. Hum Mol Genet, 16:2651–2658. 2007.
363.
Martinez–RuizG, MaldonadoV, Ceballos–CancinoG, GrajedaJP, Melendez–ZajglaJ. Role of Smac/DIABLO in cancer progression. J Exp Clin Cancer Res, 27:48. 2008.
364.
MathupalaSP, KoYH, PedersenPL. Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy. Semin Cancer Biol, 19:17–24. 2009.
365.
McBrideHM, NeuspielM, WasiakS. Mitochondria: More than just a powerhouse. Curr Biol, 16:R551–R560. 2006.
366.
MehrotraS, KakkarP, ViswanathanPN. Mitochondrial damage by active oxygen species in vitro. Free Radic Biol Med, 10:277–285. 1991.
367.
MeisterA. Glutathione biosynthesis and its inhibition. Methods Enzymol, 252:26–30. 1995.
MelovS, TarnopolskyMA, BeckmanK, FelkeyK, HubbardA. Resistance exercise reverses aging in human skeletal muscle. PLoS ONE, 2:e465. 2007.
372.
MerkwirthC, DargazanliS, TatsutaT, GeimerS, LowerB, WunderlichFT, von Kleist-RetzowJC, WaismanA, WestermannB, LangerT. Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes Dev, 22:476–488. 2008.
373.
MerkwirthC, LangerT. Mitofusin 2 builds a bridge between ER and mitochondria. Cell, 135:1165–1167. 2008.
374.
MerkwirthC, LangerT. Prohibitin function within mitochondria: Essential roles for cell proliferation and cristae morphogenesis. Biochim Biophys Acta, 1793:27–32. 2009.
375.
Milagros RochaM, VictorVM. Targeting antioxidants to mitochondria and cardiovascular diseases: The effects of mitoquinone. Med Sci Monit, 13:RA132–RA145. 2007.
376.
MioY, BienengraeberMW, MarinovicJ, GuttermanDD, RakicM, BosnjakZJ, StadnickaA. Age-related attenuation of isoflurane preconditioning in human atrial cardiomyocytes: Roles for mitochondrial respiration and sarcolemmal adenosine triphosphate-sensitive potassium channel activity. Anesthesiology, 108:612–620. 2008.
377.
MioY, ShimYH, RichardsE, BosnjakZJ, PagelPS, BienengraeberM. Xenon preconditioning: the role of prosurvival signaling, mitochondrial permeability transition and bioenergetics in rats. Anesth Analg, 108:858–866. 2009.
378.
MisakiN, MaoX, LiNYF, SugaS, LiGH, LiuQ, ChangY, WangH, WakuiM, WuJ. Iptakalim, a vascular ATP-sensitive potassium (KATP) channel opener, closes rat pancreatic beta-cell KATP channels and increases insulin release. J Pharmacol Exp Ther, 322:871–878. 2007.
379.
MitchellP. Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. Biol Rev Camb Philos Soc, 41:445–502. 1966.
380.
MiyamaeM, CamachoSA, WeinerMW, FigueredoVM. Attenuation of postischemic reperfusion injury is related to prevention of [Ca2+]m overload in rat hearts. Am J Physiol, 271:H2145–H2153. 1996.
381.
MiyamotoS, MurphyAN, BrownJH. Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II. Cell Death Differ, 15:521–529. 2008.
382.
MockfordKA, GirnHR, Homer–VanniasinkamS. Postconditioning: Current controversies and clinical implications. Eur J Vasc Endovasc Surg, 37:437–442. 2009.
383.
MohanJ, GandhiAA, BhavyaBC, RashmiR, KarunagaranD, InduR, SanthoshkumarTR. Caspase-2 triggers Bax-Bak-dependent and -independent cell death in colon cancer cells treated with resveratrol. J Biol Chem, 281:17599–17611. 2006.
MosconiL. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imag, 32:486–510. 2005.
388.
MullerFL, LustgartenMS, JangY, RichardsonA, Van RemmenH. Trends in oxidative aging theories. Free Radic Biol Med, 43:477–503. 2007.
389.
MullerFL, SongW, LiuY, ChaudhuriA, Pieke–DahlS, StrongR, HuangTT, EpsteinCJ, RobertsLJ2nd, CseteM, FaulknerJA, Van RemmenH. Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radic Biol Med, 40:1993–2004. 2006.
390.
MurakamiK, MizoueT, SasakiS, OhtaM, SatoM, MatsushitaY, MishimaN. Dietary intake of folate, other B vitamins, and omega-3 polyunsaturated fatty acids in relation to depressive symptoms in Japanese adults. Nutrition, 24:140–147. 2008.
391.
MuravchickS, LevyRJ. Clinical implications of mitochondrial dysfunction. Anesthesiology, 105:819–837. 2006.
392.
MuroC, GrigorievSM, PietkiewiczD, KinnallyKW, CampoML. Comparison of the TIM and TOM channel activities of the mitochondrial protein import complexes. Biophys J, 84:2981–2989. 2003.
393.
MurphyMP. Selective targeting of bioactive compounds to mitochondria. Trends Biotechnol, 15:326–330. 1997.
394.
MythriRB, JagathaB, PradhanN, AndersenJ, BharathMM. Mitochondrial complex I inhibition in Parkinson's disease: How can curcumin protect mitochondria?Antioxid Redox Signal, 9:399–408. 2007.
395.
NadtochiySM, BakerPR, FreemanBA, BrookesPS. Mitochondrial nitroalkene formation and mild uncoupling in ischaemic preconditioning: Implications for cardioprotection. Cardiovasc Res, 82:333–340. 2009.
396.
NadtochiySM, BurwellLS, BrookesPS. Cardioprotection and mitochondrial S-nitrosation: effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia-reperfusion injury. J Mol Cell Cardiol, 42:812–825. 2007.
397.
NagaKK, SullivanPG, GeddesJW. High cyclophilin D content of synaptic mitochondria results in increased vulnerability to permeability transition. J Neurosci, 27:7469–7475. 2007.
NichollsDG. Mitochondrial function and dysfunction in the cell: Its relevance to aging and aging-related disease. Int J Biochem Cell Biol, 34:1372–1381. 2002.
400.
NicolayK, TimmersRJ, SpoelstraE, Van der NeutR, FokJJ, HuigeNYM, VerkleijAJ, De KruijffB. The interaction of adriamycin with cardiolipin in model and rat liver mitochondrial membranes. Biochim Biophys Acta, 778:359–371. 1984.
401.
NicolsonGL. Metabolic syndrome and mitochondrial function: Molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function. J Cell Biochem, 100:1352–1369. 2007.
402.
NicolsonGL, ConklinKA. Reversing mitochondrial dysfunction, fatigue and the adverse effects of chemotherapy of metastatic disease by molecular replacement therapy. Clin Exp Metastasis, 25:161–169. 2008.
403.
NilakantanV, ZhouX, HiltonG, ShiY, BakerJE, KhannaAK, PieperGM. Antagonizing reactive oxygen by treatment with a manganese (III) metalloporphyrin-based superoxide dismutase mimetic in cardiac transplants. J Thor Cardiovasc Surg, 131:898–906. 2006.
404.
NingXH, XuCS, SongYC, ChildsKF, XiaoY, BollingSF, LupinettiFM, PortmanMA. Temperature threshold and modulation of energy metabolism in the cardioplegic arrested rabbit heart. Cryobiology, 36:2–11. 1998.
405.
NishikawaT, ArakiE. [Investigation of a novel mechanism of diabetic complications: Impacts of mitochondrial reactive oxygen species]Rinsho Byori, 56:712–719. 2008.
406.
NistalaR, Whaley–ConnellA, SowersJR. Redox control of renal function and hypertension. Antioxid Redox Signal, 10:2047–2089. 2008.
407.
NohlH. Generation of superoxide radicals as byproduct of cellular respiration. Ann Biol Clin (Paris), 52:199–204. 1994.
408.
NovalijaE, KevinLG, CamaraAK, BosnjakZJ, KampineJP, StoweDF. Reactive oxygen species precede the epsilon isoform of protein kinase C in the anesthetic preconditioning signaling cascade. Anesthesiology, 99:421–428. 2003.
409.
NovalijaE, VaradarajanSG, CamaraAKS, AnJZ, ChenQ, RiessML, HoggH, StoweDF. Anesthetic preconditioning: Triggering role of reactive oxygen and nitrogen species in isolated hearts. Am J Physiol Heart Circ Physiol, 283:H44–H52. 2002.
410.
NozoeM, HirookaY, KogaY, ArakiS, KonnoS, KishiT, IdeT, SunagawaK. Mitochondria-derived reactive oxygen species mediate sympathoexcitation induced by angiotensin II in the rostral ventrolateral medulla. J Hypertens, 26:2176–2184. 2008.
411.
O'RourkeB. Mitochondrial ion channels. Annu Rev Physiol, 69:19–49. 2007.
412.
O'RourkeB, CortassaS, AonMA. Mitochondrial ion channels: Gatekeepers of life and death. Physiology (Bethesda), 20:303–315. 2005.
413.
OakesSA, ScorranoL, OpfermanJT, BassikMC, NishinoM, PozzanT, KorsmeyerSJ. Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum. Proc Natl Acad Sci USA, 102:105–110. 2005.
414.
ObameFN, ZiniR, SouktaniR, BerdeauxA, MorinD. Peripheral benzodiazepine receptor-induced myocardial protection is mediated by inhibition of mitochondrial membrane permeabilization. J Pharmacol Exp Ther, 323:336–345. 2007.
415.
OberleyLW. Mechanism of the tumor suppressive effect of MnSOD overexpression. Biomed Pharmacother, 59:143–148. 2005.
416.
OchiaiK, ZhangJ, GongG, ZhangY, LiuJ, YeY, WuX, LiuH, MurakamiY, BacheRJ, UgurbilK, FromAH. Effects of augmented delivery of pyruvate on myocardial high-energy phosphate metabolism at high workstate. Am J Physiol Heart Circ Physiol, 281:H1823–H1832. 2001.
417.
OgbiM, JohnsonJA. Protein kinase Cepsilon interacts with cytochrome c oxidase subunit IV and enhances cytochrome c oxidase activity in neonatal cardiac myocyte preconditioning. Biochem J, 393:191–199. 2006.
418.
OhnishiST, OhnishiT, MuranakaS, FujitaH, KimuraH, UemuraK, YoshidaK, UtsumiK. A possible site of superoxide generation in the complex I segment of rat heart mitochondria. J Bioenerg Biomembr, 37:1–15. 2005.
419.
OhsawaI, KaminoK, NagasakaK, AndoF, NiinoN, ShimokataH, OhtaS. Genetic deficiency of a mitochondrial aldehyde dehydrogenase increases serum lipid peroxides in community-dwelling females. J Hum Genet, 48:404–409. 2003.
420.
OkadaSF, O'NealWK, HuangP, NicholasRA, OstrowskiLE, CraigenWJ, LazarowskiER, BoucherRC. Voltage-dependent anion channel-1 (VDAC-1) contributes to ATP release and cell volume regulation in murine cells. J Gen Physiol, 124:513–526. 2004.
421.
OkiC, WatanabeY, YokoyamaH, ShimodaT, KatoH, ArakiT. Delayed treatment with arundic acid reduces the MPTP-induced neurotoxicity in mice. Cell Mol Neurobiol, 28:417–430. 2008.
422.
OkunJG, LummenP, BrandtU. Three classes of inhibitors share a common binding domain in mitochondrial complex I (NADH:ubiquinone oxidoreductase)J Biol Chem, 274:2625–2630. 1999.
423.
OnyangoIG. Mitochondrial dysfunction and oxidative stress in Parkinson's disease. Neurochem Res, 33:589–597. 2008.
424.
OrzaezM, MondragonL, MarzoI, SanclimensG, MesseguerA, Perez–PayaE, VicentMJ. Conjugation of a novel Apaf-1 inhibitor to peptide-based cell-membrane transporters: Effective methods to improve inhibition of mitochondria-mediated apoptosis. Peptides, 28:958–968. 2007.
425.
OsipovAN, StepanovGO, VladimirovYA, KozlovAV, KaganVE. Regulation of cytochrome C peroxidase activity by nitric oxide and laser irradiation. Biochemistry (Mosc), 71:1128–1132. 2006.
426.
OuttenCE, CulottaVC. A novel NADH kinase is the mitochondrial source of NADPH in Saccharomyces cerevisiae. EMBO J, 22:2015–24. 2003.
427.
OwenMR, DoranE, HalestrapAP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J, 348:607–614. 2000.
428.
PagelPS. Postconditioning by volatile anesthetics: Salvaging ischemic myocardium at reperfusion by activation of prosurvival signaling. J Cardiothorac Vasc Anesth, 22:753–765. 2008.
429.
PagelPS, KrolikowskiJG, AmourJ, WarltierDC, WeihrauchD. Morphine reduces the threshold of helium preconditioning against myocardial infarction: The role of opioid receptors in rabbits. J Cardiothorac Vasc Anesth, 23:619–624. 2009.
430.
PaiHV, StarkeDW, LesnefskyEJ, HoppelCL, MieyalJJ. What is the functional significance of the unique location of glutaredoxin 1 (GRx1) in the intermembrane space of mitochondria?Antioxid Redox Signal, 9:2027–2033. 2007.
PapaS, De RasmoD, ScaccoS, SignorileA, Technikova–DobrovaZ, PalmisanoG, SardanelliAM, PapaF, PanelliD, ScaringiR, SanteramoA. Mammalian complex I: A regulable and vulnerable pacemaker in mitochondrial respiratory function. Biochim Biophys Acta, 1777:719–728. 2008.
439.
ParkKS, ChanJC, ChuangLM, SuzukiS, ArakiE, NanjoK, JiL, NgM, NishiM, FurutaH, ShirotaniT, AhnBY, ChungSS, MinHK, LeeSW, KimJH, ChoYM, LeeHK. A mitochondrial DNA variant at position 16189 is associated with type 2 diabetes mellitus in Asians. Diabetologia, 51:602–608. 2008.
440.
ParkerJCJr.Commentary: Human mitochondrial cytopathies. Ann Clin Lab Sci, 30:159–162. 2000.
PasinelliP, BelfordME, LennonN, BacskaiBJ, HymanBT, TrottiD, BrownRHJr.Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron, 43:19–30. 2004.
443.
PastorinoJG, HoekJB. Regulation of hexokinase binding to VDAC. J Bioenerg Biomembr, 40:171–182. 2008.
444.
PastorinoJG, HoekJB, ShulgaN. Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res, 65:10545–10554. 2005.
445.
PatelMN. Metalloporphyrins improve the survival of Sod2-deficient neurons. Aging Cell, 2:219–222. 2003.
446.
PattiME, ButteAJ, CrunkhornS, CusiK, BerriaR, KashyapS, MiyazakiY, KohaneI, CostelloM, SacconeR, LandakerEJ, GoldfineAB, MunE, DeFronzoR, FinlaysonJ, KahnCR, MandarinoLJ. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci USA, 100:8466–8471. 2003.
447.
PedersenPL, MathupalaS, RempelA, GeschwindJF, KoYH. Mitochondrial bound type II hexokinase: A key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim Biophys Acta, 1555:14–20. 2002.
448.
PelicanoH, XuRH, DuM, FengL, SasakiR, CarewJS, HuY, RamdasL, HuL, KeatingMJ, ZhangW, PlunkettW, HuangP. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol, 175:913–923. 2006.
449.
PepeS. Mitochondrial function in ischaemia and reperfusion of the ageing heart. Clin Exp Pharmacol Physiol, 27:745–750. 2000.
PicklesJO. Mutation in mitochondrial DNA as a cause of presbyacusis. Audiol Neurootol, 9:23–33. 2004.
452.
PintonP, RimessiA, MarchiS, OrsiniF, MigliaccioE, GiorgioM, ContursiC, MinucciS, MantovaniF, WieckowskiMR, Del SalG, PelicciPG, RizzutoR. Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science, 315:659–663. 2007.
453.
PopeS, LandJM, HealesSJ. Oxidative stress and mitochondrial dysfunction in neurodegeneration; Cardiolipin a critical target?Biochim Biophys Acta, 1777:794–799. 2008.
454.
PraetM, LaghmicheM, PollakisG, GoormaghtighE, RuysschaertJM. In vivo and in vitro modifications of the mitochondrial membrane induced by 4' Epi-adriamycin. Biochem Pharmacol, 35:2923–2928. 1986.
455.
PraetM, RuysschaertJM. In vivo and in vitro mitochondrial membrane damages induced in mice by adriamycin and derivatives. Biochim Biophys Acta, 1149:79–85. 1993.
456.
PravdicDB, SedlicM, F, StadnickaA, BosnjakZ. Intracellular Ca2+ and pH modulation of in cardiomyocytes during postconditioning. Anesthesiology, 109:A-859. 2008.
457.
PrellerA, WilsonJE. Localization of the type III isozyme of hexokinase at the nuclear periphery. Arch Biochem Biophys, 294:482–492. 1992.
458.
PriorSL, GriffithsAP, BaxterJM, BaxterPW, HodderSC, SilvesterKC, LewisPD. Mitochondrial DNA mutations in oral squamous cell carcinoma. Carcinogenesis, 27:945–950. 2006.
459.
ProuskyJ, SeelyD. The treatment of migraines and tension-type headaches with intravenous and oral niacin (nicotinic acid): Systematic review of the literature. Nutr J, 4:3. 2005.
460.
QuilesJL, Ramirez–TortosaMC, HuertasJR, IbanezS, GomezJA, BattinoM, MataixJ. Olive oil supplemented with vitamin E affects mitochondrial coenzyme Q levels in liver of rats after an oxidative stress induced by adriamycin. Biofactors, 9:331–336. 1999.
461.
RadiR, CassinaA, HodaraR, QuijanoC, CastroL. Peroxynitrite reactions and formation in mitochondria. Free Radical Biol Med, 33:1451–1464. 2002.
462.
RadiR, PeluffoG, AlvarezMN, NaviliatM, CayotaA. Unraveling peroxynitrite formation in biological systems. Free Radical Biol and Med, 30:463–488. 2001.
463.
RadiR, TurrensJF, ChangLY, BushKM, CrapoJD, FreemanBA. Detection of catalase in rat heart mitochondria. J Biol Chem, 266:22028–22034. 1991.
464.
RajuTN. The Nobel chronicles. 1931: Otto Heinrich Warburg (1883–1970)Lancet, 352:2028. 1998.
465.
RapoportM, SaadaA, ElpelegO, Lorberboum–GalskiH. TAT-mediated delivery of LAD restores pyruvate dehydrogenase complex activity in the mitochondria of patients with LAD deficiency. Mol Ther, 16:691–697. 2008.
466.
RappaportL, OlivieroP, SamuelJL. Cytoskeleton and mitochondrial morphology and function. Mol Cell Biochem, 184:101–105. 1998.
467.
RathoreR, ZhengYM, NiuCF, LiuQH, KordeA, HoYS, WangYX. Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2+]i through the mitochondrial ROS-PKCepsilon signaling axis in pulmonary artery smooth muscle cells. Free Radic Biol Med, 45:1223–1231. 2008.
468.
RavagnanL, MarzoI, CostantiniP, SusinSA, ZamzamiN, PetitPX, HirschF, GoulbernM, PouponMF, MiccoliL, XieZ, ReedJC, KroemerG. Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore. Oncogene, 18:2537–2546. 1999.
469.
RazeghiP, YoungME, CockrillTC, FrazierOH, TaegtmeyerH. Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure. Circulation, 106:407–411. 2002.
470.
ReaumeAG, ElliottJL, HoffmanEK, KowallNW, FerranteRJ, SiwekDF, WilcoxHM, FloodDG, BealMF, BrownRHJr., ScottRW, SniderWD. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet, 13:43–47. 1996.
471.
ReynenK, BachmannK. Coronary arteriography in elderly patients: Risk, therapeutic consequences and long-term follow-up. Coron Artery Dis, 8:657–666. 1997.
472.
RicciC, PastukhV, LeonardJ, TurrensJ, WilsonG, SchafferD, SchafferSW. Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis. Am J Physiol Cell Physiol, 294:C413–C422. 2008.
473.
RidnourLA, OberleyTD, OberleyLW. Tumor suppressive effects of MnSOD overexpression may involve imbalance in peroxide generation versus peroxide removal. Antioxid Redox Signal, 6:501–512. 2004.
474.
RiessML, CamaraAK, HeinenA, EellsJT, HenryMM, StoweDF. KATP channel openers have opposite effects on mitochondrial respiration under different energetic conditions. J Cardiovasc Pharmacol, 51:483–491. 2008.
475.
RiessML, CamaraAK, KevinLG, AnJ, StoweDF. Reduced reactive O2 species formation and preserved mitochondrial NADH and [Ca2+] levels during short-term 17°C ischemia in intact hearts. Cardiovasc Res, 61:580–590. 2004.
476.
RiessML, KevinLG, McCormickJ, JiangMT, RhodesSS, StoweDF. Anesthetic preconditioning: The role of free radicals in sevoflurane-induced attenuation of mitochondrial electron transport in Guinea pig isolated hearts. Anesth Analg, 100:46–53. 2005.
477.
RiessML, StoweDF, WarltierDC. Cardiac pharmacological preconditioning with volatile anesthetics: From bench to bedside?Am J Physiol Heart Circ Physiol, 286:H1603–H1607. 2004.
478.
RodriguezAM, CarricoPM, MazurkiewiczJE, MelendezJA. Mitochondrial or cytosolic catalase reverses the MnSOD-dependent inhibition of proliferation by enhancing respiratory chain activity, net ATP production, and decreasing the steady state levels of H2O2. Free Radic Biol Med, 29:801–813. 2000.
479.
RogersRJ, MonnierJM, NickHS. Tumor necrosis factor-alpha selectively induces MnSOD expression via mitochondria-to-nucleus signaling, whereas interleukin-1beta utilizes an alternative pathway. J Biol Chem, 276:20419–20427. 2001.
480.
RollinsB, MartinMV, SequeiraPA, MoonEA, MorganLZ, WatsonSJ, SchatzbergA, AkilH, MyersRM, JonesEG, WallaceDC, BunneyWE, VawterMP. Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder. PLoS One, 4:e4913. 2009.
481.
RoscaMG, VazquezEJ, KernerJ, ParlandW, ChandlerMP, StanleyW, SabbahHN, HoppelCL. Cardiac mitochondria in heart failure: Decrease in respirasomes and oxidative phosphorylation. Cardiovasc Res, 80:30–9. 2008.
482.
RosiniM, AndrisanoV, BartoliniM, BolognesiML, HreliaP, MinariniA, TarozziA, MelchiorreC. Rational approach to discover multipotent anti-Alzheimer drugs. J Med Chem, 48:360–363. 2005.
483.
RossiL, LombardoMF, CirioloMR, RotilioG. Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance. Neurochem Res, 29:493–504. 2004.
484.
RotigA, de LonlayP, ChretienD, FouryF, KoenigM, SidiD, MunnichA, RustinP. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet, 17:215–217. 1997.
485.
RuckenstuhlC, ButtnerS, Carmona–GutierrezD, EisenbergT, KroemerG, SigristSJ, FröhlichKU, MadeoF. The Warburg effect suppresses oxidative stress induced apoptosis in a yeast model for cancer. PLoS ONE, 4:4592. 2009.
486.
Ruiz–MeanaM, Garcia–DoradoD, PinaP, InserteJ, AgulloL, Soler–SolerJ. Cariporide preserves mitochondrial proton gradient and delays ATP depletion in cardiomyocytes during ischemic conditions. Am J Physiol Heart Circ Physiol, 285:H999–H1006. 2003.
487.
RushJD, KoppenolWH. Oxidizing intermediates in the reaction of ferrous EDTA with hydrogen peroxide. Reactions with organic molecules and ferrocytochrome c. J Biol Chem, 261:6730–6733. 1986.
488.
RushJD, MaskosZ, KoppenolWH. Distinction between hydroxyl radical and ferryl species. Methods Enzymol, 186:148–156. 1990.
489.
RustinP, MunnichA, RotigA. Quinone analogs prevent enzymes targeted in Friedreich ataxia from iron-induced injury in vitro. Biofactors, 9:247–51. 1999.
490.
RustinP, von Kleist-RetzowJC, Chantrel–GroussardK, SidiD, MunnichA, RotigA. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: A preliminary study. Lancet, 354:477–479. 1999.
491.
RybnikovaE, DamdimopoulosAE, GustafssonJA, SpyrouG, Pelto–HuikkoM. Expression of novel antioxidant thioredoxin-2 in the rat brain. Eur J Neurosci, 12:1669–1678. 2000.
SackMN, RaderTA, ParkS, BastinJ, McCuneSA, KellyDP. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation, 94:2837–2842. 1996.
494.
SalardiS, ZucchiniS, ElleriD, GrossiG, BargossiAM, GualandiS, SantoniR, CicognaniA, CacciariE. High glucose levels induce an increase in membrane antioxidants, in terms of vitamin E and coenzyme Q10 in children and adolescents with type 1 diabetes. Diabetes Care, 27:630–631. 2004.
495.
SalvadorA, SousaJ, PintoRE. Hydroperoxyl, superoxide and pH gradients in the mitochondrial matrix: A theoretical assessment. Free Radic Biol Med, 31:1208–1215. 2001.
496.
ScarpullaRC. Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells. Gene, 286:81–89. 2002.
497.
SchapiraAH. Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia. Biochim Biophys Acta, 1410:159–170. 1999.
SchapiraAH, CooperJM, DexterD, JennerP, ClarkJB, MarsdenCD. Mitochondrial complex I deficiency in Parkinson's disease. Lancet, 1:1269. 1989.
500.
SchimkeI, SchikoraM, MeyerR, DubelHP, ModersohnD, KleberFX, BaumannG. Oxidative stress in the human heart is associated with changes in the antioxidative defense as shown after heart transplantation. Mol Cell Biochem, 204:89–96. 2000.
SchonEA, DiMauroS. Medicinal and genetic approaches to the treatment of mitochondrial disease. Curr Med Chem, 10:2523–2533. 2003.
503.
SchonfeldP, WojtczakL. Fatty acids decrease mitochondrial generation of reactive oxygen species at the reverse electron transport but increase it at the forward transport. Biochim Biophys Acta, 1767:1032–1040. 2007.
504.
SchrinerSE, LinfordNJ, MartinGM, TreutingP, OgburnCE, EmondM, CoskunPE, LadigesW, WolfN, Van RemmenH, WallaceDC, RabinovitchPS. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science, 308:1909–1911. 2005.
505.
SchurksM, DienerHC, GoadsbyP. Update on the prophylaxis of migraine. Curr Treat Options Neurol, 10:20–29. 2008.
506.
SchwartzM, VissingJ. Paternal inheritance of mitochondrial DNA. N Engl J Med, 347:576–580. 2002.
507.
SchwarzeSR, HoA, Vocero–AkbaniA, DowdySF. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science, 285:1569–1572. 1999.
508.
SedlicF, WakatsukiT, PravdicD, BosnjakZ. Mitochondrial membrane potential regulates production of reactive oxygen species and opening of permeability transition pore. FASEB J, 23:576.3. 2009.
509.
SeibelP, TrappeJ, VillaniG, KlopstockT, PapaS, ReichmannH. Transfection of mitochondria: Strategy towards a gene therapy of mitochondrial DNA diseases. Nucleic Acids Res, 23:10–17. 1995.
510.
SenCK. Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem Pharmacol, 55:1747–1758. 1998.
SeoBB, MarellaM, YagiT, Matsuno–YagiA. The single subunit NADH dehydrogenase reduces generation of reactive oxygen species from complex I. FEBS Lett, 580:6105–6108. 2006.
513.
ServiddioG, Di VenosaN, FedericiA, D'AgostinoD, RolloT, PrigigalloF, AltomareE, FioreT, VendemialeG. Brief hypoxia before normoxic reperfusion (postconditioning) protects the heart against ischemia-reperfusion injury by preventing mitochondria peroxyde production and glutathione depletion. FASEB J, 19:354–361. 2005.
SharifMA, BayraktutanU, AryaN, BadgerSA, O'DonnellME, YoungIS, SoongCV. Effects of antioxidants on endothelial function in human saphenous vein in an ex vivo model. Angiology, 60:448–454. 2009.
517.
SharovVG, TodorAV, SilvermanN, GoldsteinS, SabbahHN. Abnormal mitochondrial respiration in failed human myocardium. J Mol Cell CardioL, 32:2361–2367. 2000.
518.
SheridanC, DelivaniP, CullenSP, MartinSJ. Bax- or Bak-induced mitochondrial fission can be uncoupled from cytochrome C release. Mol Cell, 31:570–585. 2008.
519.
SheuSS, NauduriD, AndersMW. Targeting antioxidants to mitochondria: A new therapeutic direction. Biochim Biophys Acta, 1762:256–265. 2006.
520.
ShiQ, XuH, KleinmanWA, GibsonGE. Novel functions of the alpha-ketoglutarate dehydrogenase complex may mediate diverse oxidant-induced changes in mitochondrial enzymes associated with Alzheimer's disease. Biochim Biophys Acta, 1782:229–238. 2008.
521.
ShigenagaMK, AboujaoudeEN, ChenQ, AmesBN. Assays of oxidative DNA damage biomarkers 8-oxo-2′-deoxyguanosine and 8-oxoguanine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection. Methods Enzymol, 234:16–33. 1994.
522.
Shimoda–MatsubayashiS, MatsumineH, KobayashiT, Nakagawa–HattoriY, ShimizuY, MizunoY. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun, 226:561–565. 1996.
523.
Shoshan–BarmatzV, ZakarM, RosenthalK, Abu–HamadS. Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase. Biochim Biophys Acta, 1787:421–430. 2009.
524.
ShroffEH, SnyderC, ChandelNS. Role of Bcl-2 family members in anoxia induced cell death. Cell Cycle, 6:807–809. 2007.
SinghIN, SullivanPG, HallED. Peroxynitrite-mediated oxidative damage to brain mitochondria: Protective effects of peroxynitrite scavengers. J Neurosci Res, 85:2216–2223. 2007.
528.
SivitzWI, YorekMA. Mitochondrial dysfunction in diabetes: From molecular mechanisms to functional significance and therapeutic opportunities. Antioxid Redox Signal, 12:537–577. 2010.
529.
SkulachevVP. Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductants. Q Rev Biophys, 29:169–202. 1996.
530.
SmailiSS, RussellJT. Permeability transition pore regulates both mitochondrial membrane potential and agonist-evoked Ca2+ signals in oligodendrocyte progenitors. Cell Calcium, 26:121–130. 1999.
531.
SmeitinkJA, ZevianiM, TurnbullDM, JacobsHT. Mitochondrial medicine: A metabolic perspective on the pathology of oxidative phosphorylation disorders. Cell Metab, 3:9–13. 2006.
532.
SmithRA, PorteousCM, CoulterCV, MurphyMP. Selective targeting of an antioxidant to mitochondria. Eur J Biochem, 263:709–716. 1999.
533.
SolainiG, HarrisDA. Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochem J, 390:377–394. 2005.
SrinivasulaSM, GuptaS, DattaP, ZhangZ, HegdeR, CheongN, Fernandes–AlnemriT, AlnemriES. Inhibitor of apoptosis proteins are substrates for the mitochondrial serine protease Omi/HtrA2. J Biol Chem, 278:31469–31472. 2003.
536.
St-PierreJ, BuckinghamJA, RoebuckSJ, BrandMD. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem, 277:44784–44790. 2002.
537.
St-PierreJ, DroriS, UldryM, SilvaggiJM, RheeJ, JagerS, HandschinC, ZhengK, LinJ, YangW, SimonDK, BachooR, SpiegelmanBM. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell, 127:397–408. 2006.
538.
StanleyWC, LopaschukGD, McCormackJG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res, 34:25–33. 1997.
539.
StanleyWC, RecchiaFA, LopaschukGD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev, 85:1093–1129. 2005.
540.
StarkR, RodenM. ESCI Award 2006. Mitochondrial function and endocrine diseases. Eur J Clin Invest, 37:236–248. 2007.
541.
StarkeDW, CheNY, BapnaCP, LesnefskyEJ, MieyalJJ. Sensitivity of protein sulfhydryl repair enzymes to oxidative stress. Free Radic Biol Med, 23:373–384. 1997.
542.
StoweDF, AldakkakM, CamaraAKS, RiessML, HeinenA, VaradarajanSG, JiangMT. Cardiac mitochondrial preconditioning by big Ca2+-sensitive K+ channel opening requires superoxide radical generation. Am J Physiol Heart Circ Physiol, 290:H434–H440. 2006.
543.
StoweDF, CamaraAKS. Mitochondrial reactive oxygen species production in excitable cells: Modulators of mitochondrial and cell function. Antioxid Redox Signal, 11:1373–1396. 2009.
544.
StuartJA, CadenasS, JekabsonsMB, RousselD, BrandMD. Mitochondrial proton leak and the uncoupling protein 1 homologues. Biochim Biophys Acta, 1504:144–158. 2001.
545.
SuYA, WuJ, ZhangL, ZhangQ, SuDM, HeP, WangBD, LiH, WebsterMJ, RennertOM, UrsanoRJ. Dysregulated mitochondrial genes and networks with drug targets in postmortem brain of patients with posttraumatic stress disorder (PTSD) revealed by human mitochondria-focused cDNA microarrays. Int J Biol Sci, 4:223–235. 2008.
SunHY, WangNP, KerendiF, HalkosM, KinH, GuytonRA, Vinten–JohansenJ, ZhaoZQ. Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation and intracellular Ca2+ overload. Am J Physiol Heart Circ Physiol, 288:H1900–H1908. 2005.
548.
SunKH, de PabloY, VincentF, ShahK. Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction. J Neurochem, 107:265–278. 2008.
549.
SunL, ShukairS, NaikTJ, MoazedF, ArdehaliH. Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II. Mol Cell Biol, 28:1007–1017. 2008.
550.
SzabadkaiG, DuchenMR. Mitochondria: The hub of cellular Ca2+ signaling. Physiology (Bethesda), 23:84–94. 2008.
SzewczykA, SkalskaJ, GlabM, KulawiakB, MalinskaD, Koszela–PiotrowskaI, KunzWS. Mitochondrial potassium channels: From pharmacology to function. Biochim Biophys Acta, 1757:715–720. 2006.
556.
SzewczykA, WojtczakL. Mitochondria as a pharmacological target. Pharmacol Rev, 54:101–127. 2002.
557.
TabriziSJ, CleeterMW, XuerebJ, TaanmanJW, CooperJM, SchapiraAH. Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann Neurol, 45:25–32. 1999.
558.
TaegtmeyerH. Switching metabolic genes to build a better heart. Circulation, 106:2043–2045. 2002.
559.
TaegtmeyerH. Cardiac metabolism as a target for the treatment of heart failure. Circulation, 110:894–896. 2004.
560.
TaegtmeyerH, McNultyP, YoungME. Adaptation and maladaptation of the heart in diabetes: Part I: General concepts. Circulation, 105:1727–1733. 2002.
561.
TaegtmeyerH, OverturfML. Effects of moderate hypertension on cardiac function and metabolism in the rabbit. Hypertension, 11:416–426. 1988.
562.
TaguchiN, IshiharaN, JofukuA, OkaT, MiharaK. Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J Biol Chem, 282:11521–11529. 2007.
563.
TakaokaS, IwaseM, UchidaM, YoshibaS, KondoG, WatanabeH, OhashiM, NagumoM, ShintaniS. Effect of combining epidermal growth factor receptor inhibitors and cisplatin on proliferation and apoptosis of oral squamous cell carcinoma cells. Int J Oncol, 30:1469–1476. 2007.
564.
TanL, YuJT, GuanHS. Resveratrol exerts pharmacological preconditioning by activating PGC-1alpha. Med Hypotheses, 71:664–667. 2008.
565.
TaniM, HonmaY, HasegawaH, TamakiK. Direct activation of mitochondrial KATP channels mimics preconditioning but protein kinase C activation is less effective in middle-aged rat hearts. Cardiovasc Res, 49:56–68. 2001.
566.
TarbaC, CraciumC. A comparative study of the effects of procaine, lidocaine, tetracaine and dibucaine on the functions and ultrastructure of isolated rat liver mitochondria. Biochim Biophys Acta, 1019:19–28. 1990.
567.
TaylorRW, ChinneryPF, TurnbullDM, LightowlersRN. Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nat Genet, 15:212–215. 1997.
TeshimaY, AkaoM, JonesSP, MarbanE. Uncoupling protein-2 overexpression inhibits mitochondrial death pathway in cardiomyocytes. Circ Res, 93:192–200. 2003.
570.
TewariA, AliA, O'DonnellA, ButtMS. Weight loss and 2,4-dinitrophenol poisoning. Br J Anaesth, 102:566–567. 2009.
571.
ThannickalVJ, FanburgBL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol, 279:L1005–L1028. 2000.
572.
TheruvathTP, SnoddyMC, ZhongZ, LemastersJJ. Mitochondrial permeability transition in liver ischemia and reperfusion: role of c-Jun N-terminal kinase 2. Transplantation, 85:1500–1504. 2008.
573.
TheruvathTP, ZhongZ, PediaditakisP, RamsheshVK, CurrinRT, TikunovA, HolmuhamedovE, LemastersJJ. Minocycline and N-methyl-4-isoleucine cyclosporin (NIM811) mitigate storage/reperfusion injury after rat liver transplantation through suppression of the mitochondrial permeability transition. Hepatology, 47:236–246. 2008.
TonissenKF, Di TrapaniG. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy. Mol Nutr Food Res, 53:87–103. 2009.
576.
TorresJ, SharpeMA, RosquistA, CooperCE, WilsonMT. Cytochrome c oxidase rapidly metabolises nitric oxide to nitrite. FEBS Letters, 475:263–266. 2000.
577.
TreutingPM, LinfordNJ, KnoblaughSE, EmondMJ, MortonJF, MartinGM, RabinovitchPS, LadigesWC. Reduction of age-associated pathology in old mice by overexpression of catalase in mitochondria. J Gerontol A Biol Sci Med Sci, 63:813–822. 2008.
578.
TrifunovicA, LarssonNG. Mitochondrial dysfunction as a cause of ageing. J Intern Med, 263:167–178. 2008.
579.
TuliniusMH, HolmeE, KristianssonB, LarssonNG, OldforsA. Mitochondrial encephalomyopathies in childhood. II. Clinical manifestations and syndromes. J Pediat, 119:251–259. 1991.
580.
TurrensJF, AlexandreA, LehningerAL. Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem Biophys, 237:408–414. 1985.
581.
TurrensJF, BoverisA. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J, 191:421–427. 1980.
582.
UedaS, NakamuraH, MasutaniH, SasadaT, YoneharaS, TakabayashiA, YamaokaY, YodoiJ. Redox regulation of caspase-3(-like) protease activity: Regulatory roles of thioredoxin and cytochrome c. J Immunol, 161:6689–6695. 1998.
583.
UjwalR, CascioD, ColletierJP, FahamS, ZhangJ, ToroL, PingP, AbramsonJ. The crystal structure of mouse VDAC1 at 2.3 A resolution reveals mechanistic insights into metabolite gating. Proc Natl Acad Sci USA, 105:17742–17747. 2008.
584.
ValdezLB, AlvarezS, ArnaizSL, SchopferF, CarrerasMC, PoderosoJJ, BoverisA. Reactions of peroxynitrite in the mitochondrial matrix. Free Radic Biol Med, 29:349–356. 2000.
585.
ValenG, VaageJ. Pre- and postconditioning during cardiac surgery. Basic Res Cardiol, 100:179–186. 2005.
586.
ValentineJS, DoucettePA, Zittin PotterS. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu Rev Biochem, 74:563–593. 2005.
587.
ValentineJS, HartPJ. Misfolded CuZnSOD and amyotrophic lateral sclerosis. Proc Natl Acad Sci USA, 100:3617–3622. 2003.
588.
ValleA, GuevaraR, Garcia-PalmerFJ, RocaP, OliverJ. Caloric restriction retards the age-related decline in mitochondrial function of brown adipose tissue. Rejuvenation Res, 11:597–604. 2008.
589.
ValleI, Alvarez–BarrientosA, ArzaE, LamasS, MonsalveM. PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovasc Res, 66:562–573. 2005.
590.
Van RaamsdonkJM, HekimiS. Deletion of the mitochondrial superoxide dismutase sod-2 extends lifespan in Caenorhabditis elegans. PLoS Genet, 5:e1000361. 2009.
591.
Vanden HoekTL, LiC, ShaoZ, SchumackerPT, BeckerLB. Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol, 29:2571–2583. 1997.
592.
Vanden HoekTL, ShaoZ, LiC, SchumackerPT, BeckerLB. Mitochondrial electron transport can become a significant source of oxidative injury in cardiomyocytes. J Mol Cell Cardiol, 29:2441–2450. 1997.
593.
VaradarajanSC, RhodesSS, AldakkakM, HeisnerJS, StoweDF. Cardiac mitochondrial Ca2 -dependent big K+ channels are open during reperfusion. FASEB J, 21:A1224. 2007.
594.
VarbiroG, TothA, TapodiA, BognarZ, VeresB, SumegiB, GallyasFJr.Protective effect of amiodarone but not N-desethylamiodarone on postischemic hearts through the inhibition of mitochondrial permeability transition. J Pharmacol Exp Ther, 307:615–625. 2003.
VenkatakrishnanP, NakayasuES, AlmeidaIC, MillerRT. Absence of nitric-oxide synthase in sequentially purified rat liver mitochondria. J Biol Chem, 284:19843–19855. 2009.
597.
VerhagenAM, EkertPG, PakuschM, SilkeJ, ConnollyLM, ReidGE, MoritzRL, SimpsonRJ, VauxDL. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell, 102:43–53. 2000.
598.
VijayasarathyC, BiunnoI, LenkaN, YangM, BasuA, HallIP, AvadhaniNG. Variations in the subunit content and catalytic activity of the cytochrome c oxidase complex from different tissues and different cardiac compartments. Biochim Biophys Acta, 1371:71–82. 1998.
599.
Vinten–JohansenJ, YellonDM, OpieLH. Postconditioning: A simple, clinically applicable procedure to improve revascularization in acute myocardial infarction. Circulation, 112:2085–2088. 2005.
600.
Vinten–JohansenJ, ZhaoZQ, ZattaAJ, KinH, HalkosME, KerendiF. Postconditioning–A new link in nature's armor against myocardial ischemia-reperfusion injury. Basic Res Cardiol, 100:295–310. 2005.
WaldmeierPC, ZimmermannK, QianT, Tintelnot–BlomleyM, LemastersJJ. Cyclophilin D as a drug target. Curr Med Chem, 10:1485–1506. 2003.
603.
WalenskyLD, KungAL, EscherI, MaliaTJ, BarbutoS, WrightRD, WagnerG, VerdineGL, KorsmeyerSJ. Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science, 305:1466–1470. 2004.
604.
WallJA, WeiJ, LyM, BelmontP, MartindaleJJ, TranD, SunJ, ChenWJ, YuW, OellerP, BriggsS, GustafssonAB, SayenMR, GottliebRA, GlembotskiCC. Alterations in oxidative phosphorylation complex proteins in the hearts of transgenic mice that overexpress the p38 MAP kinase activator, MAP kinase kinase 6. Am J Physiol Heart Circ Physiol, 291:H2462–H2472. 2006.
605.
WalshC, BarrowS, VoronicaS, ChvanovM, PetersenOH. Tepikin T Modulation of calcium signalling by mitochondria. Biochem Biophys Acta, 1787:1374–1382. 2009.
606.
WangH, LimPJ, KarbowskiM, MonteiroMJ. Effects of overexpression of huntingtin proteins on mitochondrial integrity. Hum Mol Genet, 18:737–752. 2009.
607.
WangT, LiuB, QinL, WilsonB, HongJS. Protective effect of the SOD/catalase mimetic MnTMPyP on inflammation-mediated dopaminergic neurodegeneration in mesencephalic neuronal-glial cultures. J Neuroimmunol, 147:68–72. 2004.
608.
WangX, PerezE, LiuR, YanLJ, MalletRT, YangSH. Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cells. Brain Res, 1132:1–9. 2007.
609.
WangZB, LiM, ZhaoY, XuJX. Cytochrome C is a hydrogen peroxide scavenger in mitochondria. Protein Pept Lett, 10:247–253. 2003.
610.
WaypaGB, MarksJD, MackMM, BoribounC, MungaiPT, SchumackerPT. Mitochondrial reactive oxygen species trigger calcium increases during hypoxia in pulmonary arterial myocytes. Circ Res, 91:719–726. 2002.
611.
WebbA, BondR, McLeanP, UppalR, BenjaminN, AhluwaliaA. Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Proc Natl Acad Sci USA, 101:13683–13688. 2004.
WenzelP, MollnauH, OelzeM, SchulzE, WickramanayakeJM, MullerJ, SchuhmacherS, HortmannM, BaldusS, GoriT, BrandesRP, MunzelT, DaiberA. First evidence for a crosstalk between mitochondrial and NADPH oxidase-derived reactive oxygen species in nitroglycerin-triggered vascular dysfunction. Antioxid Redox Signal, 10:1435–1447. 2008.
WhiteC, LiC, YangJ, PetrenkoNB, MadeshM, ThompsonCB, FoskettJK. The endoplasmic reticulum gateway to apoptosis by Bcl-X(L) modulation of the InsP3R. Nat Cell Biol, 7:1021–1028. 2005.
616.
WhitnallM, RahmantoYS, SutakR, XuX, BeckerEM, MikhaelMR, PonkaP, RichardsonDR. The MCK mouse heart model of Friedreich's ataxia: Alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation. Proc Natl Acad Sci USA, 105:9757–97-62. 2008.
WiedemannN, van der LaanM, PfannerN. SnapShot: Import and sorting of mitochondrial proteins. Cell, 138:808–808 e1. 2009.
619.
WilcoxCS, PearlmanA. Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol Rev, 60:418–469. 2008.
620.
WillisSN, ChenL, DewsonG, WeiA, NaikE, FletcherJI, AdamsJM, HuangDC. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Devel, 19:1294–1305. 2005.
621.
WingroveDE, GunterTE. Kinetics of mitochondrial calcium transport. I. Characteristics of the sodium-independent calcium efflux mechanism of liver mitochondria. J Biol Chem, 261:15159–15165. 1986.
622.
WitteAV, FobkerM, GellnerR, KnechtS, FloelA. Caloric restriction improves memory in elderly humans. Proc Natl Acad Sci USA, 106:1255–1260. 2009.
623.
WolfHP. Possible new therapeutic approach in diabetes mellitus by inhibition of carnitine palmitoyltransferase 1 (CPT1)Horm Metab Res Suppl, 26:62–67. 1992.
624.
WolinMS, AhmadM, GupteSA. Oxidant and redox signaling in vascular oxygen sensing mechanisms: Basic concepts, current controversies, and potential importance of cytosolic NADPH. Am J Physiol Lung Cell Mol Physiol, 289:L159–L173. 2005.
625.
WoodZA, SchroderE, Robin HarrisJ, PooleLB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci, 28:32–40. 2003.
626.
Woyda-PloszczycaA, JarmuszkiewiczW. [Uncoupling proteins in modulation of mitochondrial functions–therapeutic prospects]Postepy Biochem, 54:188–197. 2008.
627.
WrightEJr., Scism-BaconJL, GlassLC. Oxidative stress in type 2 diabetes: The role of fasting and postprandial glycaemia. Int J Clin Pract, 60:308–314. 2006.
628.
WuG, ChaiJ, SuberTL, WuJW, DuC, WangX, ShiY. Structural basis of IAP recognition by Smac/DIABLO. Nature, 408:1008–1012. 2000.
YokoyamaH, KuroiwaH, YanoR, ArakiT. Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease. Neurol Sci, 29:293–301. 2008.
639.
YokoyamaH, YanoR, AokiE, KatoH, ArakiT. Comparative pharmacological study of free radical scavenger, nitric oxide synthase inhibitor, nitric oxide synthase activator and cyclooxygenase inhibitor against MPTP neurotoxicity in mice. Metab Brain Dis, 23:335–349. 2008.
640.
YoungME, McNultyP, TaegtmeyerH. Adaptation and maladaptation of the heart in diabetes: Part II: Potential mechanisms. Circulation, 105:1861–1870. 2002.
641.
YousufS, AtifF, AhmadM, HodaN, IshratT, KhanB, IslamF. Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain Res, 1250:242–253. 2009.
642.
YuJ, WangP, MingL, WoodMA, ZhangL. SMAC/Diablo mediates the proapoptotic function of PUMA by regulating PUMA-induced mitochondrial events. Oncogene, 26:4189–4198. 2007.
643.
ZabihiS, WentzelP, ErikssonUJ. Maternal blood glucose levels determine the severity of diabetic embryopathy in mice with different expression of copper-zinc superoxide dismutase (CuZnSOD)Toxicol Sci, 105:166–172. 2008.
ZhangJ, MurakamiY, ZhangY, ChoYK, YeY, GongG, BacheRJ, UgurbilK, FromAH. Oxygen delivery does not limit cardiac performance during high work states. Am J Physiol, 277:H50–H57. 1999.
ZhangY, BaY, LiuC, SunG, DingL, GaoS, HaoJ, YuZ, ZhangJ, ZenK, TongZ, XiangY, ZhangCY. PGC-1alpha induces apoptosis in human epithelial ovarian cancer cells through a PPARgamma-dependent pathway. Cell Res, 17:363–373. 2007.
648.
ZhangY, MarcillatO, GiuliviC, ErnsterL, DaviesKJ. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J Biol Chem, 265:16330–16336. 1990.
649.
ZhaoH. Ischemic postconditioning as a novel avenue to protect against brain injury after stroke. J Cereb Blood Flow Metab, 29:873–885. 2009.
650.
ZhaoQ, WangJ, LevichkinIV, StasinopoulosS, RyanMT, HoogenraadNJ. A mitochondrial specific stress response in mammalian cells. EMBO J, 21:4411–4419. 2002.
651.
ZhaoY, LuN, LiH, ZhangY, GaoZ, GongY. High glucose induced human umbilical vein endothelial cell injury: involvement of protein tyrosine nitration. Mol Cell Biochem, 311:19–29. 2008.
652.
ZhaoY, WangZB, XuJX. Effect of cytochrome c on the generation and elimination of O2•− and H2O2 in mitochondria. J Biol Chem, 278:2356–2360. 2003.
653.
ZiegerMA, GuptaMP. Hypothermic preconditioning of endothelial cells attenuates cold-induced injury by a ferritin-dependent process. Free Radic Biol Med, 46:680–691. 2009.
654.
ZimmermanMC, OberleyLW, FlanaganSW. Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels. J Neurochem, 102:609–618. 2007.
655.
ZmijewskiJW, LorneE, ZhaoX, TsurutaY, ShaY, LiuG, SiegalGP, AbrahamE. Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury. Am J Respir Crit Care Med, 178:168–179. 2008.
656.
ZoccaratoF, CavalliniL, BortolamiS, AlexandreA. Succinate modulation of H2O2 release at NADH:ubiquinone oxidoreductase (Complex I) in brain mitochondria. Biochem J, 406:125–129. 2007.
657.
ZorovDB, FilburnCR, KlotzLO, ZweierJL, SollottSJ. Reactive oxygen species (ROS)-induced ROS release: A new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med, 192:1001–1014. 2000.
